on the advice of the Minister of Health tendered after consultation with the organisations or bodies appearing to the Minister to be representative of persons likely to be substantially affected.

1	Title
2	Commencement
3	Principal regulations
4	Schedule 1 replaced
5	Regulations revoked
	Schedule Schedule 1 replaced
	Explanatory note
	Gazette Information
	Reprint notes

Regulations

1 Title

These regulations are the Medicines Amendment Regulations 2018.

2 Commencement

These regulations come into force on the 28th day after the date of their notification in the Gazette.

3 Principal regulations

These regulations amend the Medicines Regulations 1984 (the principal regulations).

4 Schedule 1 replaced

Replace Schedule 1 with the Schedule 1 set out in the Schedule of these regulations.

5 Regulations revoked

The Medicines Amendment Regulations (No 2) 2015 (LI 2015/180) are revoked.

Schedule Schedule 1 replaced

r 4

Schedule 1 Prescription, restricted, and pharmacy-only medicines

r 3

Every reference to a medicine in this schedule applies whether the medicine is synthetic in origin or is from biological or mineral sources.

Unless specific reference is made otherwise, every reference applies also to medicines that are—

•

preparations and admixtures containing any proportion of any substance listed in this schedule:

•

salts and esters of any substance listed in this schedule:

•

preparations or extracts of biological materials listed in this schedule:

•

salts or oxides of elements listed in this schedule.

Unless specific reference is made otherwise, every reference to a medicine in this schedule applies,—

•

if the medicine is an injection or eye preparation, to any concentration of that medicine; and

•

if the medicine is not an injection or eye preparation, only if the concentration of the medicine is greater than 10 milligrams per litre or per kilogram.

Where any reference is modified by a statement of the strength of the medicine, the strength is calculated using the free acid, base, alcohol, or element unless specifically stated otherwise.

Part 1 Prescription medicines

Amending or replacing this Part may affect designated prescriber regulations under section 105(1)(q) of the Act.

1

19-norandrostenedione

2

2,4-dinitrochlorobenzene

3

4-aminopyridine

4

4-chloromethandienone

5

4-chlorotestosterone

6

5-aminolevulinic acid

7

Abacavir

8

Abatacept

9

Abciximab

10

Abiraterone

11

Abrus precatorius; at all strengths

12

Acamprosate

13

Acarbose

14

Acebutolol

15

Acepromazine

16

Acetanilides

17

Acetarsol

18

Acetazolamide

19

Acetohexamide

20

Acetylcarbromal

21

Acetylcholine; except in medicines containing 1 milligram or less per litre or per kilogram

22

Acetylcysteine; for injection or inhalation

23

Acetyldigitoxin

24

Acetylmethyldimethyloximidophenylhydrazine

25

Acetylstrophanthidin

26

Aciclovir; except when specified elsewhere in this schedule

27

Acipimox

28

Acitretin

29

Aclidinium bromide

30

Acokanthera ouabaio

31

Acokanthera schimperi

32

Aconitum spp; except when specified elsewhere in this schedule

33

Acrivastine

34

Adalimumab

35

Adapalene; except in medicines containing 1 milligram or less per millilitre or gram and when supplied by a pharmacist in a pack containing not more than 30 grams for the treatment of comedo, popular, and pustular acne (acne vulgaris) of the face, chest, or back

36

Adefovir

37

Adenosine; for injection

38

Adinazolam

39

Adiphenine

40

Adonis vernalis

41

Adrafinil

42

Adrenal extract; except for dermal use in medicines containing 0.02% or less of ketosteroids

43

Adrenaline; in medicines containing more than 1%

44

Adrenocortical hormones; except adrenal extract for dermal use containing 0.02% or less of ketosteroids

45

Afamelanotide

46

Afatinib

47

Aflibercept

48

Agalsidase

49

Agomelatine

50

Alatrofloxacin

51

Albendazole

52

Albumin; except human albumin

53

Alclofenac

54

Alclometasone; except when specified elsewhere in this schedule

55

Alcohol; for injection in medicines containing more than 20%

56

Alcuronium

57

Aldesleukin

58

Aldosterone; except in medicines containing 10 micrograms or less per litre or per kilogram

59

Alectinib

60

Alefacept

61

Alemtuzumab

62

Alendronic acid

63

Alfacalcidol

64

Alfentanil

65

Alfuzosin

66

Alglucerase

67

Alglucosidase

68

Alirocumab

69

Aliskiren

70

Alkyl sulfonals

71

Allergens

72

Allopurinol

73

Allylisopropylacetylurea; at all strengths

74

Allyloestrenol

75

Alogliptin

76

Aloracetam

77

Alosetron

78

Alpha₁-proteinase inhibitor

79

Alphadolone

80

Alphaxalone

81

Alprazolam

82

Alprenolol

83

Alprostadil

84

Alseroxylon

85

Alteplase

86

Altretamine

87

Amantadine

88

Ambenonium

89

Ambrisentan

90

Ambucetamide

91

Ambutonium

92

Amcinonide

93

Amethocaine; except when specified elsewhere in this schedule; for ophthalmic use except when used in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board

94

Amfebutamone

95

Amfepramone

96

Amidopyrine

97

Amifampridine

98

Amifostine

99

Amikacin

100

Amiloride

101

Aminocaproic acid

102

Aminoglutethimide

103

Aminometradine

104

Aminophenazone; at all strengths

105

Aminophylline; except when specified elsewhere in this schedule

106

Aminopterin

107

Aminorex

108

Aminosalicylic acid

109

Amiodarone

110

Amiphenazole

111

Amisometradine

112

Amisulpride

113

Amitriptyline

114

Amlodipine

115

Ammi visnaga

116

Ammonium bromide

117

Amobarbital

118

Amodiaquine

119

Amorolfine; except when specified elsewhere in this schedule; except in preparations for the treatment of tinea pedis only or when sold in practice by a podiatrist registered with the Podiatrists Board

120

Amoxapine

121

Amoxycillin

122

Amphomycin

123

Amphotericin

124

Ampicillin

125

Amprenavir

126

Amrinone

127

Amsacrine

128

Amygdalin; at all strengths

129

Amyl nitrite; except when sold to a person who is appropriately authorised under the Health and Safety at Work Act 2015

130

Amylocaine

131

Anabolic steroids

132

Anagrelide

133

Anakinra

134

Anastrozole

135

Ancestim

136

Anchusa officinalis; at all strengths

137

Ancrod and its immunoglobulin antidote

138

Androgenic and anabolic steroidal agents

139

Androgens

140

Androisoxazole

141

Androstanolone

142

Androstenediol

143

Androstenedione

144

Anecortave

145

Angiotensinamide

146

Anidulafungin

147

Aniracetam

148

Anistreplase

149

Antazoline; except for ophthalmic use

150

Antibiotic substances; except when specified elsewhere in this schedule

151

Antigens

152

Antihistamines; except when specified elsewhere in this schedule

153

Antimony; except in medicines containing 1 milligram or less per litre or per kilogram

154

Antisera; for injection

155

AOD-9604

156

Apalutamide

157

Apixaban

158

Apocynum spp

159

Apomorphine; except in medicines containing 1 milligram or less per litre or per kilogram

160

Apraclonidine

161

Apremilast

162

Aprepitant

163

Apronal

164

Aprotinin

165

Arecoline

166

Aripiprazole

167

Aristolochia spp; at all strengths

168

Aristolochic acid; at all strengths

169

Armodafinil

170

Arsenic; except in medicines containing 1 milligram or less per litre or per kilogram

171

Artemether

172

Artesunate

173

Articaine; except when used as a local anaesthetic in practice by a dental therapist or oral health therapist registered with the Dental Council

174

Asenapine

175

Asfotase alfa

176

Asparaginase

177

Aspirin; except when specified elsewhere in this schedule; for injection; when combined with caffeine, paracetamol, or salicylamide

178

Astemizole

179

Asunaprevir

180

Atamestane

181

Atazanavir

182

Atenolol

183

Atezolizumab

184

Atomoxetine

185

Atorvastatin

186

Atosiban

187

Atovaquone

188

Atracurium

189

Atropa belladonna; except when specified elsewhere in this schedule; except in medicines containing 300 micrograms or less of total solanaceous alkaloids per litre or per kilogram

190

Atropine; except when specified elsewhere in this schedule; except when used as an antidote in a device designed for self-injection; except in medicines containing 300 micrograms or less per litre or per kilogram

191

Atropine methonitrate

192

Auranofin

193

Aurothiomalate sodium

194

Avanafil

195

Aviptadil

196

Axitinib

197

Azacitidine

198

Azacyclonol

199

Azapropazone

200

Azaribine

201

Azatadine; except when specified elsewhere in this schedule

202

Azathioprine

203

Azelaic acid; except when specified elsewhere in this schedule

204

Azelastine; except when specified elsewhere in this schedule

205

Azithromycin

206

Azlocillin

207

Aztreonam

208

Bacampicillin

209

Bacitracin

210

Baclofen

211

Balsalazide

212

Bambuterol

213

Bamethan

214

Bamipine

215

Barbital

216

Barbiturates

217

Basiliximab

218

Bazedoxifene

219

Becaplermin

220

Beclamide

221

Beclomethasone; except when specified elsewhere in this schedule

222

Bedaquiline

223

Belatacept

224

Belimumab

225

Bemegride

226

Benactyzine

227

Benazepril

228

Bendamustine

229

Bendrofluazide

230

Benethamine penicillin

231

Benorylate

232

Benoxaprofen

233

Benperidol

234

Benserazide

235

Benzathine penicillin

236

Benzatropine

237

Benzbromarone

238

Benzhexol

239

Benzilonium

240

Benzocaine; except when specified elsewhere in this schedule

241

Benzodiazepine derivatives; except when specified elsewhere in this schedule

242

Benzodiazepines; except when specified elsewhere in this schedule

243

Benzoyl metronidazole

244

Benzoyl peroxide; except when specified elsewhere in this schedule

245

Benzthiazide

246

Benzydamine; except when specified elsewhere in this schedule

247

Benzylpenicillin

248

Bepridil

249

Beractant

250

Besifloxacin

251

Beta carotene; in medicines containing more than 18 milligrams per recommended daily dose

252

Betahistine

253

Betaine; for the treatment of homocystinuria

254

Betamethasone

255

Betaxolol

256

Bethanechol

257

Bethanidine

258

Bevacizumab

259

Bevantolol

260

Bexarotene

261

Bezafibrate

262

Bezlotoxumab

263

Bicalutamide

264

Bictegravir

265

Bifonazole; except when specified elsewhere in this schedule

266

Bilastine; except when specified elsewhere in this schedule

267

Bimatoprost

268

Binimetinib

269

Biperiden

270

Bismuth; except for external use in medicines containing 3% or less

271

Bisoprolol

272

Bithionol; at all strengths

273

Bivalirudin

274

Bleomycin

275

Boceprevir

276

Bolandiol

277

Bolasterone

278

Bolazine

279

Boldenone

280

Bolenol

281

Bolmantalate

282

Boron, including borax and boric acid; except in medicines for internal use containing 6 milligrams or less per recommended daily dose; except in medicines for dermal use other than paediatric use containing 0.35% or less; except when present as an excipient

283

Bortezomib

284

Bosentan

285

Bosutinib

286

Botulinum toxins

287

Brentuximab vedotin

288

Bretylium

289

Brexpiprazole

290

Brimonidine

291

Brinzolamide

292

Brivaracetam (and its stereoisomers)

293

Bromazepam

294

Bromocriptine

295

Bromoform

296

Brompheniramine; except when specified elsewhere in this schedule

297

Bromvaletone

298

Brotizolam

299

Brugmansia spp

300

Buclizine; except for oral use

301

Budesonide; except when specified elsewhere in this schedule

302

Bufexamac; except in suppositories; except for dermal use in medicines containing 5% or less

303

Bumetanide

304

Buniodyl sodium; at all strengths

305

Buphenine

306

Bupivacaine

307

Buprenorphine

308

Bupropion

309

Buserelin

310

Buspirone

311

Busulphan

312

Butacaine

313

Butobarbital

314

Butoconazole; except for vaginal use

315

Butorphanol

316

Butyl aminobenzoate; except in medicines for dermal use containing 2% or less

317

Butyl nitrite

318

Butylchloral hydrate

319

Cabazitaxel

320

Cabergoline

321

Cabozantinib

322

Cacalia spp; at all strengths

323

Cadmium

324

Calcipotriol; except in medicines containing not more than 50 micrograms per gram or per millilitre and when sold in a pack of not more than 30 grams or 30 millilitres by a pharmacist to an adult with mild to moderate psoriasis previously diagnosed by a doctor

325

Calcitonin

326

Calcitriol

327

Calcium carbimide

328

Calcium polystyrene sulphonate

329

Calotropis gigantea

330

Calotropis procera

331

Calusterone

332

Camazepam

333

Camphorated oil

334

Camphotamide

335

Canagliflozin

336

Canakinumab

337

Candesartan

338

Candicidin

339

Cannabidiol

340

Capecitabine

341

Capreomycin

342

Captodiame

343

Captopril

344

Capuride

345

Caramiphen

346

Carbachol

347

Carbamazepine

348

Carbaryl; except for external use in medicines containing 2% or less

349

Carbazochrome

350

Carbenicillin

351

Carbenoxolone; except for external use

352

Carbetocin

353

Carbidopa

354

Carbimazole

355

Carbocromen

356

Carboplatin

357

Carboprost

358

Carbromal

359

Carbutamide

360

Carbuterol

361

Carfilzomib

362

Carglumic acid

363

Carindacillin

364

Carisoprodol

365

Carmustine

366

Carprofen

367

Carvedilol

368

Caspofungin

369

Catumaxomab

370

Cebaracetam (and its stereoisomers)

371

Cefacetrile

372

Cefaclor

373

Cefaloridine

374

Cefamandole

375

Cefapirin

376

Cefazolin

377

Cefepime

378

Cefetamet

379

Cefixime

380

Cefodizime

381

Cefonicid

382

Cefoperazone

383

Cefotaxime

384

Cefotetan

385

Cefotiam

386

Cefoxitin

387

Cefpirome

388

Cefpodoxime

389

Cefsulodin

390

Ceftaroline fosamil

391

Ceftazidime

392

Ceftibuten

393

Ceftolozane

394

Ceftriaxone

395

Cefuroxime

396

Celecoxib

397

Celiprolol

398

Cephaelis acuminata; except in medicines containing less than 0.2% of emetine

399

Cephaelis ipecacuanha; except in medicines containing less than 0.2% of emetine

400

Cephalexin

401

Cephalothin

402

Cephradine

403

Ceritinib

404

Cerivastatin

405

Certolizumab pegol

406

Ceruletide

407

Cetirizine; except when specified elsewhere in this schedule

408

Cetrorelix

409

Cetuximab

410

Chenodeoxycholic acid

411

Chloral hydrate; except for dermal use in medicines containing 2% or less

412

Chloralformamide

413

Chloralose

414

Chlorambucil

415

Chloramphenicol; except when sold in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board; except when specified elsewhere in this schedule

416

Chlorandrostenolone

417

Chlorazanil

418

Chlorcyclizine

419

Chlordiazepoxide

420

Chlormerodrin

421

Chlormethiazole

422

Chlormezanone

423

Chloroform; for anaesthesia; except when specified elsewhere in this schedule

424

Chloroquine

425

Chlorothiazide

426

Chlorotrianisene

427

Chloroxydienone

428

Chloroxymesterone

429

Chlorpheniramine; except when specified elsewhere in this schedule

430

Chlorphentermine

431

Chlorpromazine

432

Chlorpropamide

433

Chlorprothixene

434

Chlorquinaldol

435

Chlortetracycline

436

Chlorthalidone

437

Chlorzoxazone

438

Cholera vaccine; except in the form of an oral liquid containing vibrio cholerae when sold in a pharmacy by a registered pharmacist

439

Cholic acid

440

Choline salicylate; except in medicines containing 10% or less and in pack sizes of 15 grams or less

441

Chorionic gonadotrophin; except in pregnancy test kits

442

Chymopapain

443

Ciclacillin

444

Ciclesonide

445

Ciclopirox; except when specified elsewhere in this schedule

446

Cidofovir

447

Cilastatin

448

Cilazapril

449

Cilostazol

450

Cimetidine; except when specified elsewhere in this schedule

451

Cinacalcet

452

Cinchocaine; for injection; for ophthalmic use; for external use in medicines containing more than 0.5%

453

Cinchophen

454

Cinnarizine

455

Cinoxacin

456

Ciprofloxacin

457

Cisapride

458

Cisatracurium

459

Cisplatin

460

Citalopram

461

CJC-1295

462

Cladribine

463

Clarithromycin

464

Clavulanic acid

465

Clemastine; except for oral use

466

Clemizole

467

Clenbuterol

468

Clevidipine

469

Clidinium

470

Clindamycin

471

Clioquinol; at all strengths

472

Clobazam

473

Clobetasol

474

Clobetasone; except when specified elsewhere in this schedule

475

Clocortolone

476

Clodronic acid

477

Clofarabine

478

Clofazimine

479

Clofenamide

480

Clofibrate

481

Clomiphene

482

Clomipramine

483

Clomocycline

484

Clonazepam

485

Clonidine

486

Clopamide

487

Clopidogrel

488

Clorazepic acid

489

Clorexolone

490

Clorprenaline

491

Clostebol

492

Clotiazepam

493

Clotrimazole; except when specified elsewhere in this schedule

494

Cloxacillin

495

Cloxazolam

496

Clozapine

497

Cobalt

498

Cobicistat

499

Cobimetinib

500

Cocaine; except when specified elsewhere in this schedule

501

Codeine; except when specified elsewhere in this schedule

502

Co-dergocrine

503

Colaspase

504

Colchicine

505

Colchicum

506

Colecalciferol; except in medicines containing 25 micrograms or less per recommended daily dose; except in parenteral nutrition replacement preparations

507

Colestipol

508

Colestyramine

509

Colfosceril

510

Colistin

511

Collagen; in injections or implants for tissue augmentation or cosmetic use

512

Collagenase clostridium histolyticum

513

Coluracetam

514

Conium maculatum; at all strengths

515

Convallaria keiski

516

Convallaria majalis

517

Corifollitropin alfa

518

Coronilla spp

519

Corticosterone

520

Corticotrophin

521

Cortisone and other steroidal hormones of the adrenal cortex; except when specified elsewhere in this schedule; except adrenal extract for dermal use in medicines containing 0.02% or less of ketosteroids

522

Cotarnine; at all strengths

523

Co-trimoxazole

524

Coumarin

525

Crizotinib

526

Crofelemer

527

Crotalaria spp; at all strengths

528

Croton tiglium; except in medicines containing 1 milligram or less per litre or per kilogram

529

Crystal violet

530

Curare

531

Cyclandelate

532

Cyclizine; except when specified elsewhere in this schedule

533

Cyclobenzaprine

534

Cyclofenil

535

Cycloheximide

536

Cyclopenthiazide

537

Cyclopentolate; except when used in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board

538

Cyclophosphamide

539

Cyclopropane

540

Cycloserine

541

Cyclosporin

542

Cyclothiazide

543

Cycrimine

544

Cymarin

545

Cynoglossum spp; at all strengths

546

Cyproheptadine; except for oral use

547

Cyproterone

548

Cysteamine

549

Cytarabine

550

Dabigatran

551

Dabrafenib mesilate

552

Dacarbazine

553

Daclatasvir

554

Daclizumab

555

Dactinomycin

556

Dalfopristin

557

Dalteparin

558

Danaparoid

559

Danazol

560

Danthron

561

Dantrolene

562

Dapagliflozin

563

Dapoxetine

564

Dapsone

565

Daptomycin

566

Daratumumab

567

Darbepoetin

568

Darifenacin

569

Darunavir

570

Dasabuvir

571

Dasatinib

572

Datura spp; except for oral use when specified elsewhere in this schedule; except datura stramonium or datura tatula for smoking or burning

573

Daunorubicin

574

Deanol

575

Debrisoquine

576

Decamethonium

577

Deferasirox

578

Deferiprone

579

Defibrotide

580

Deflazacort

581

Degarelix

582

Dehydrochloromethyltestosterone

583

Dehydrocorticosterone

584

Delavirdine

585

Delorazepam

586

Demecarium

587

Demeclocycline

588

Denosumab

589

Deoxycortone

590

Deoxycholic acid; for injection; except for oral use

591

Deoxyribonuclease; except for external use

592

Dermatophagoides farina allergen extract

593

Dermatophagoides pteronyssinus allergen extract

594

Desferrioxamine

595

Desflurane

596

Desipramine

597

Desirudin

598

Deslanoside

599

Desloratadine; except for oral use

600

Deslorelin

601

Desmopressin

602

Desogestrel; except when supplied for oral contraception to women who meet the clinical and eligbility criteria of the Pharmacy Council and the Pharmaceutical Society of New Zealand Incorporated approved training programme on oral contraception, when sold in the manufacturer’s original pack that has received the consent of the Minister or Director-General to their distribution as medicines, containing not more than 6 months’ supply by a registered pharmacist who has successfully completed the approved training programme

603

Desonide

604

Desoximetasone

605

Desvenlafaxine

606

Dexamethasone

607

Dexamfetamine

608

Dexchlorpheniramine; except when specified elsewhere in this schedule

609

Dexfenfluramine

610

Dexmedetomidine

611

Dextromethorphan; except when specified elsewhere in this schedule

612

Dextromoramide

613

Dextropropoxyphene

614

Dextrorphan

615

Di-iodohydroxy quinoline; except when specified elsewhere in this schedule

616

Di-isopropylamine dichloroacetate

617

Diazepam

618

Diazoxide

619

Dibenzepin

620

Dibotermin

621

Dibrompropamidine; except for ophthalmic use

622

Dichloralphenazone

623

Dichlorophen

624

Dichlorphenamide

625

Diclofenac; in preparations for the treatment of solar keratosis; except when specified elsewhere in this schedule; except in preparations for topical use other than for the treatment of solar keratosis

626

Dicloxacillin

627

Dicyclomine

628

Didanosine

629

Dienoestrol

630

Dienogest

631

Diethazine

632

Diethylcarbamazine

633

Diethylstilbestrol

634

Diflorasone

635

Diflucortolone

636

Diflunisal

637

Digitalis lanata

638

Digitalis purpurea

639

Digitoxin

640

Digoxin

641

Digoxin-specific antibody fragment

642

Dihydralazine

643

Dihydrocodeine

644

Dihydroergotoxine

645

Dihydrolone

646

Dihydrotachysterol

647

Diltiazem

648

Dimenhydrinate; except when specified elsewhere in this schedule

649

Dimercaprol

650

Dimethandrostanolone

651

Dimethazine

652

Dimethindene; except for oral use

653

Dimethothiazine

654

Dimethoxanate

655

Dimethyl fumarate

656

Dimethyl sulphoxide

657

Dimiracetam (and its stereoisomers)

658

Dinitrocresols

659

Dinitronaphthols

660

Dinitrophenols

661

Dinitrothymols

662

Dinoprost

663

Dinoprostone

664

Diperodon

665

Diphemanil; except for dermal use

666

Diphenhydramine; except when specified elsewhere in this schedule

667

Diphenidol

668

Diphenoxylate; except when specified elsewhere in this schedule

669

Diphenylpyraline

670

Diphtheria, tetanus and pertussis (acellular, component) vaccine; except when administered in a single dose to a person 18 years of age or over or to a pregnant woman aged 13 years or over by a registered pharmacist who has successfully completed a vaccinator training course approved by the Ministry of Health and who is complying with the immunisation standards of the Ministry of Health

671

Diphtheria toxoid

672

Diphtheria vaccine

673

Dipivefrin

674

Dipyridamole

675

Dirithromycin

676

Disopyramide

677

Distigmine

678

Disulfiram

679

Disulphamide

680

Ditiocarb

681

Dobutamine

682

Docetaxel

683

Dofetilide

684

Dolasetron

685

Doliracetam (and its stereoisomers)

686

Dolutegravir

687

Domperidone

688

Donepezil

689

Dopamine

690

Dopexamine

691

Doripenem

692

Dornase

693

Dorzolamide

694

Dothiepin

695

Doxantrazole

696

Doxapram

697

Doxazosin

698

Doxepin

699

Doxorubicin

700

Doxycycline

701

Doxylamine; except when specified elsewhere in this schedule

702

Dronedarone

703

Droperidol

704

Drospirenone

705

Drostanolone

706

Drotrecogin

707

Duboisia leichhardtii; except when specified elsewhere in this schedule

708

Duboisia myoporides; except when specified elsewhere in this schedule

709

Dulcin; at all strengths

710

Duloxetine

711

Dupilumab

712

Dupracetam

713

Dutasteride

714

Dydrogesterone

715

Econazole; except when specified elsewhere in this schedule

716

Ecothiopate

717

Ectylurea

718

Eculizumab

719

Edetic acid; except in medicines containing 0.25% or less; except in contact lens preparations; except dicobalt edetate for the treatment of cyanide poisoning

720

Edoxudine

721

Edrophonium

722

Efalizumab

723

Efavirenz

724

Eflornithine

725

Elbasvir

726

Eletriptan

727

Elosulfase alfa

728

Elotuzumab

729

Eltrombopag olamine

730

Eluxadoline

731

Elvitegravir

732

Emepronium

733

Emetine; except in medicines containing 0.2% or less

734

Emicizumab

735

Empagliflozin

736

Emtricitabine

737

Enalapril

738

Encorafenib

739

Enestebol

740

Enflurane

741

Enfuvirtide

742

Enobosarm

743

Enoxacin

744

Enoxaparin

745

Enoximone

746

Enprostil

747

Entacapone

748

Entecavir

749

Enzalutamide

750

Ephedrine

751

Epicillin

752

Epinastine

753

Epirubicin

754

Epitiostanol

755

Eplerenone

756

Epoetins

757

Epoprostenol

758

Eprosartan

759

Eptifibatide

760

Erenumab

761

Ergocalciferol; except in medicines containing 25 micrograms or less per recommended daily dose

762

Ergometrine

763

Ergot

764

Ergotamine

765

Ergotoxine

766

Eribulin

767

Erlotinib

768

Ertapenem

769

Ertugliflozin

770

Erysimum spp; except in medicines containing 1 milligram or less per litre or per kilogram

771

Erythromycin

772

Erythropoietin

773

Escitalopram

774

Esmolol

775

Esomeprazole; except when specified elsewhere in this schedule

776

Estazolam

777

Estramustine

778

Estropipate

779

Etanercept

780

Ethacrynic acid

781

Ethambutol

782

Ethamivan

783

Ethanolamine; for injection

784

Ethchlorvynol

785

Ether; for anaesthesia; except when specified elsewhere in this schedule

786

Ethinamate

787

Ethinyloestradiol; except when supplied at a strength of 35 micrograms or less in combination with either levonorgestrel or norethisterone for oral contraception to women who meet the clinical and eligibility criteria of the Pharmacy Council and the Pharmaceutical Society of New Zealand Incorporated approved training programme on oral contraception, when sold in the manufacturer’s original pack that has received the consent of the Minister or Director-General to their distribution as medicines, containing not more than 6 months’ supply by a registered pharmacist who has successfully completed the approved trainining programme

788

Ethionamide

789

Ethisterone

790

Ethoglucid

791

Ethoheptazine

792

Ethopropazine

793

Ethosuximide

794

Ethotoin

795

Ethoxzolamide

796

Ethyl chloride; for inhalation

797

Ethyl loflazepate

798

Ethyldienolone

799

Ethylhexanediol; at all strengths

800

Ethyloestrenol

801

Ethynodiol

802

Etidocaine

803

Etidronic acid; except in medicines for external use containing 1% or less

804

Etilefrine

805

Etiracetam

806

Etodolac

807

Etofenamate; except for external use

808

Etomidate

809

Etonogestrel

810

Etoposide

811

Etoricoxib

812

Etravirine

813

Etretinate

814

Everolimus

815

Evolocumab

816

Exemestane

817

Exenatide

818

Ezetimibe

819

Factor VIII inhibitor bypassing fraction

820

Famciclovir; except when specified elsewhere in this schedule

821

Famotidine; except when specified elsewhere in this schedule

822

Fampridine

823

Farfugium japonicum; at all strengths

824

Fasoracetam (and its stereoisomers)

825

Febuxostat

826

Felbamate

827

Felbinac; except for external use

828

Felodipine

829

Felypressin; except when combined with a local anaesthetic and used in practice by a dental therapist or oral health therapist registered with the Dental Council

830

Fenbufen

831

Fenclofenac

832

Fenfluramine

833

Fenofibrate

834

Fenoldopam

835

Fenoprofen

836

Fenoterol

837

Fenpipramide

838

Fenpiprane

839

Fentanyl

840

Ferric carboxymaltose

841

Ferric derisomaltose

842

Fexofenadine; except when specified elsewhere in this schedule

843

Fibrin

844

Fibrinolysin; except for external use

845

Fibroblast growth factor

846

Fidaxomicin

847

Filgrastim

848

Finasteride

849

Fingolimod

850

Flecainide

851

Fleroxacin

852

Floctafenine

853

Fluanisone

854

Flubromazolam

855

Fluclorolone

856

Flucloxacillin

857

Fluconazole; except when specified elsewhere in this schedule

858

Flucytosine

859

Fludarabine

860

Fludiazepam

861

Fludrocortisone

862

Flufenamic acid

863

Flumazenil

864

Flumethasone

865

Flumethiazide

866

Flunarizine

867

Flunisolide

868

Flunitrazepam

869

Fluocinolone

870

Fluocinonide

871

Fluocortin

872

Fluocortolone

873

Fluorescein; for injection

874

Fluorides; for internal use in medicines containing more than 0.5 milligrams per dose unit except in medicines containing 15 milligrams or less per litre or per kilogram; except in parenteral nutrition replacement preparations; for external use in medicines containing more than 5.5 grams per litre or per kilogram except when supplied to a dental professional registered with the Dental Council

875

Fluorometholone

876

Fluorouracil

877

Fluoxetine

878

Fluoxymesterone

879

Flupenthixol

880

Fluphenazine

881

Flurandrenolone

882

Flurazepam

883

Flurbiprofen; except when specified elsewhere in this schedule

884

Fluroxene

885

Fluspirilene

886

Flutamide

887

Fluticasone; except when specified elsewhere in this schedule

888

Fluvastatin

889

Fluvoxamine

890

Folic acid; except when specified elsewhere in this schedule

891

Folinic acid; except when specified elsewhere in this schedule

892

Follicle-stimulating hormone; except in medicines containing 100 micrograms or less per litre or per kilogram

893

Follistatin

894

Follitropin

895

Follitropin delta

896

Fomepizole

897

Fomivirsen

898

Fondaparinux

899

Fonturacetam (and its stereoisomers)

900

Formebolone

901

Formestane

902

Formoterol

903

Fosamprenavir

904

Fosaprepitant

905

Foscarnet

906

Fosfestrol

907

Fosfomycin

908

Fosinopril

909

Fosphenytoin

910

Fotemustine

911

Framycetin

912

Fulvestrant

913

Furaltadone

914

Furazabol

915

Furazolidone

916

Furosemide

917

Fusidic acid

918

Gabapentin

919

Galantamine

920

Galanthus spp

921

Gallamine

922

Galsulfase

923

Ganciclovir

924

Ganirelix

925

Gatifloxacin

926

Gefitinib

927

Gemcitabine

928

Gemeprost

929

Gemfibrozil

930

Gemifloxacin

931

Gemtuzumab ozogamicin

932

Gentamicin

933

Gestodene

934

Gestonorone

935

Gestrinone

936

Ghrelin

937

Gitalin

938

Glatiramer acetate

939

Glecaprevir

940

Glibenclamide

941

Glibornuride

942

Gliclazide

943

Glimepiride

944

Glipizide

945

Glisoxepide

946

Glutathione; for injection

947

Glyceryl trinitrate; for injection; for transdermal use; except in medicines containing 100 micrograms or less per litre or per kilogram

948

Glycopyrronium

949

Glymidine

950

Golimumab

951

Gonadorelin

952

Gonadotrophic hormones; except when specified elsewhere in this schedule

953

Goserelin

954

Gramicidin

955

Granisetron

956

Grazoprevir

957

Grepafloxacin

958

Griseofulvin

959

Growth hormone releasing hormones

960

Growth hormone releasing peptide-6

961

Growth hormone releasing peptides

962

Guaifenesin; except when specified elsewhere in this schedule

963

Guanabenz

964

Guanethidine

965

Guanfacine

966

Guanidine

967

Guselkumab

968

Hachimycin

969

Haematin

970

Haemophilus influenzae vaccine; except in oral vaccines for the prophylaxis of bacterial complications of colds

971

Halazepam

972

Halcinonide

973

Halofantrine

974

Halofenate

975

Haloperidol; except in medicines containing 1 milligram or less per litre or per kilogram

976

Halothane

977

Haloxazolam

978

Halquinol; except for external use

979

Heliotropium spp; at all strengths

980

Hemerocallis

981

Heparins; except when present as an excipient; except for external use

982

Hepatitis A vaccine

983

Hepatitis B vaccine

984

Hetacillin

985

Hexachlorophane; in medicines containing more than 3%; except when specified elsewhere in this schedule

986

Hexamethonium

987

Hexarelin

988

Hexetidine; except for external use

989

Hexobendine

990

Hexocyclium

991

Hexoprenaline

992

Hexaminolevulinate

993

Histamine; except in medicines containing 0.5% or less

994

Homatropine

995

Human chorionic gonadotrophin; except in pregnancy test kits

996

Human growth hormone secretagogues

997

Human papillomavirus vaccine

998

Human protein C

999

Hyaluronic acid; in injections or implants for tissue augmentation or cosmetic use

1000

Hydralazine

1001

Hydrargaphen

1002

Hydrochlorothiazide

1003

Hydrocortisone; except when specified elsewhere in this schedule

1004

Hydrocyanic acid; except when specified elsewhere in this schedule

1005

Hydroflumethiazide

1006

Hydromorphone

1007

Hydroquinone; except when specified elsewhere in this schedule

1008

Hydroxychloroquine

1009

Hydroxyephedrine

1010

Hydroxyphenamate

1011

Hydroxyprogesterone

1012

Hydroxystenozol

1013

Hydroxyurea

1014

Hydroxyzine

1015

Hylan polymer; in injections or implants for tissue augmentation or cosmetic use

1016

Hyoscine; except when specified elsewhere in this schedule; except in medicines containing 300 micrograms or less per litre or per kilogram

1017

Hyoscine butylbromide; except when specified elsewhere in this schedule

1018

Hyoscyamine; except when specified elsewhere in this schedule; except in medicines containing 300 micrograms or less per litre or per kilogram

1019

Hyoscyamus niger; except when specified elsewhere in this schedule

1020

Hypothalamic releasing factors

1021

Hypromellose; for injection; except in intraocular viscoelastic products

1022

Ibandronic acid

1023

Ibogaine

1024

Ibritumomab tiuxetan

1025

Ibrutinib

1026

Ibufenac

1027

Ibuprofen; except when specified elsewhere in this schedule

1028

Ibuterol

1029

Ibutilide

1030

Icatibant

1031

Idarubicin

1032

Idarucizumab

1033

Idebenone

1034

Idelalisib

1035

Idoxuridine; except for dermal use in medicines containing 0.5% or less

1036

Idursulfase

1037

Ifosfamide

1038

Iloprost

1039

Imatinib

1040

Imiglucerase

1041

Imipenem

1042

Imipramine

1043

Imiquimod

1044

Immunoglobulins

1045

Imuracetam

1046

Indacaterol

1047

Indapamide

1048

Indinavir

1049

Indomethacin; except when specified elsewhere in this schedule

1050

Indoprofen

1051

Indoramin

1052

Infliximab

1053

Influenza and coryza vaccines; for injection; for nasal use

1054

Influenza vaccine; except when administered to a person 13 years of age or over by a registered pharmacist who has successfully completed a vaccinator training course approved by the Ministry of Health and who is complying with the immunisation standards of the Ministry of Health

1055

Ingenol mebutate

1056

Insulin degludec

1057

Insulin-like growth factors; except when specified elsewhere in this schedule

1058

Insulins

1059

Interferons

1060

Interleukins

1061

Iodothiouracil

1062

Ipamorelin

1063

Ipecacuanha; except when specified elsewhere in this schedule

1064

Ipilimumab

1065

Ipratropium; except for nasal use

1066

Ipriflavone

1067

Iprindole

1068

Iproniazid

1069

Irbesartan

1070

Irinotecan

1071

Iron; except when specified elsewhere in this schedule

1072

Isoaminile

1073

Isoamyl nitrite

1074

Isobutyl nitrite

1075

Isocarboxazid

1076

Isoconazole; except when specified elsewhere in this schedule

1077

Isoetarine

1078

Isoflurane

1079

Isometheptene

1080

Isoniazid

1081

Isoprenaline

1082

Isoprinosine

1083

Isopropamide; except when specified elsewhere in this schedule

1084

Isosorbide dinitrate

1085

Isosorbide mononitrate

1086

Isotretinoin

1087

Isoxicam

1088

Isoxsuprine

1089

Isradipine

1090

Itraconazole

1091

Ivabradine

1092

Ivacaftor

1093

Ivermectin

1094

Ixabepilone

1095

Ixazomib

1096

Ixekizumab

1097

Japanese encephalitis vaccine

1098

Juniperus sabina; at all strengths

1099

Kanamycin

1100

Ketamine

1101

Ketanserin

1102

Ketazolam

1103

Ketoconazole; except when specified elsewhere in this schedule

1104

Ketoprofen; except when specified elsewhere in this schedule

1105

Ketorolac

1106

Ketotifen; except for ophthalmic use in medicines containing 0.025% or less

1107

Khellin

1108

Labetalol

1109

Lacidipine

1110

Lacosamide

1111

Lamivudine

1112

Lamotrigine

1113

Lanatosides

1114

Lanreotide

1115

Lansoprazole; except when specified elsewhere in this schedule

1116

Lanthanum

1117

Lapatinib

1118

Laronidase-rch

1119

Laropiprant

1120

Latamoxef

1121

Latanoprost

1122

Laudexium

1123

Lauromacrogols; for injection

1124

Lead

1125

Ledipasvir

1126

Lefetamine

1127

Leflunomide

1128

Lenalidomide

1129

Lenograstim

1130

Lenvatinib

1131

Lepirudin

1132

Leptazol

1133

Lercanidipine

1134

Lesinurad

1135

Letermovir

1136

Letrozole

1137

Leucovorin; for injection

1138

Leuprorelin

1139

Levallorphan

1140

Levamisole

1141

Levetiracetam

1142

Levobunolol

1143

Levobupivacaine

1144

Levocabastine; except for nasal or ophthalmic use

1145

Levocetirizine; except for oral use

1146

Levodopa

1147

Levomepromazine

1148

Levomilnacipran

1149

Levonorgestrel; except when specified elsewhere in this schedule; except in medicines for use as emergency post-coital contraception when sold by nurses recognised by their professional body as having competency in the field of sexual and reproductive health; except when sold by nurses recognised by their professional body as having competency in the field of sexual and reproductive health; except when supplied for oral contraception to women who meet the clinical and eligibility criteria of the Pharmacy Council and the Pharmaceutical Society of New Zealand Incorporated approved training programme on oral contraception, when sold in the manufacturer’s original pack that has received the consent of the Minister or Director-General to their distribution as medicines, containing not more than 6 months’ supply by a registered pharmacist who has successfully completed the approved training programme

1150

Levosimendan

1151

Lidoflazine

1152

Lidocaine; for injection except when used as a local anaesthetic in practice by a nurse whose scope of practice permits the performance of general nursing functions or by a podiatrist registered with the Podiatrists Board or by a dental therapist or an oral health therapist registered with the Dental Council; for ophthalmic use except when used in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board; for oral use except in throat lozenges containing 30 milligrams or less per dose form; for external use in medicines containing more than 10%; except in throat sprays in medicines containing 2% or less; except when specified elsewhere in this schedule

1153

Ligularia dentata; at all strengths

1154

Linagliptin

1155

Lincomycin

1156

Lindane; except for external use in medicines containing 2% or less

1157

Linezolid

1158

Liothyronine

1159

Lipegfilgrastim

1160

Liraglutide

1161

Lisdexamfetamine

1162

Lisinopril

1163

Lisuride

1164

Lithium; except when specified elsewhere in this schedule; except when present as an excipient in dermal medicines containing 0.25% or less

1165

Lixisenatide

1166

Lodoxamide; except in medicines for ophthalmic use

1167

Lofexidine

1168

Lomefloxacin

1169

Lomustine

1170

Loperamide; except when specified elsewhere in this schedule

1171

Lopinavir

1172

Loprazolam

1173

Loracarbef

1174

Loratadine; except when specified elsewhere in this schedule

1175

Lorazepam

1176

Lormetazepam

1177

Losartan

1178

Loteprednol

1179

Lovastatin; except when present as an unmodified, naturally occurring substance in a food that has not been subject to a manufacturing process other than heating, freezing, drying, preserving, bottling, canning, or packaging in retort pouches

1180

Loxapine

1181

Lumacaftor

1182

Lumefantrine

1183

Lumiracoxib

1184

Lurasidone

1185

Luteinising hormone

1186

Lymecycline

1187

Macitentan

1188

Mafenide

1189

Mannomustine

1190

Maprotiline

1191

Maraviroc

1192

Mazindol

1193

Measles vaccine

1194

Mebanazine

1195

Mebeverine

1196

Mebhydrolin

1197

Mebolazine

1198

Mebutamate

1199

Mecamylamine

1200

Mecasermin

1201

Mecillinam

1202

Meclocycline

1203

Meclofenamate

1204

Meclofenoxate

1205

Meclozine; except when specified elsewhere in this schedule

1206

Medazepam

1207

Medigoxin

1208

Medroxyprogesterone

1209

Medrysone

1210

Mefenamic acid; except when specified elsewhere in this schedule

1211

Mefloquine

1212

Mefruside

1213

Megestrol

1214

Melagatran

1215

Melanocyte stimulating compounds

1216

Melatonin

1217

Melengestrol

1218

Melia azedarach; at all strengths

1219

Meloxicam

1220

Melphalan

1221

Memantine

1222

Meningococcal vaccine; except when administered to a person 16 years of age or over by a registered pharmacist who has successfully completed a vaccinator training course approved by the Ministry of Health and who is complying with the immunisation standards of the Ministry of Health

1223

Menotrophin

1224

Mepacrine

1225

Mepenzolate

1226

Mephenesin

1227

Mephentermine

1228

Mepindolol

1229

Mepitiostane

1230

Mepivacaine

1231

Mepolizumab

1232

Meprobamate

1233

Meptazinol

1234

Mepyramine; except when specified elsewhere in this schedule

1235

Mequitazine

1236

Mercaptomerin

1237

Mercaptopurine

1238

Mercurochrome; except when specified elsewhere in this schedule

1239

Mercury; except when specified elsewhere in this schedule

1240

Meropenem

1241

Mersalyl

1242

Mesabolone

1243

Mesalazine

1244

Mesna

1245

Mestanolone

1246

Mesterolone

1247

Mestranol

1248

Metamfetamine

1249

Metandienone

1250

Metaraminol

1251

Metenolone

1252

Metergoline

1253

Metformin

1254

Methacholine

1255

Methacycline

1256

Methadone

1257

Methallenoestril

1258

Methandriol

1259

Methanthelinium

1260

Methazolamide

1261

Methdilazine; except for oral use

1262

Methicillin

1263

Methimazole

1264

Methisazone

1265

Methixene

1266

Methocarbamol

1267

Methohexitone

1268

Methoin

1269

Methotrexate

1270

Methoxamine; except when specified elsewhere in this schedule

1271

Methoxsalen

1272

Methoxyflurane

1273

Methsuximide

1274

Methyclothiazide

1275

Methyl aminolevulinate

1276

Methyl androstanolone

1277

Methyl clostebol

1278

Methyl mercury; except in medicines containing 300 micrograms or less per litre or per kilogram

1279

Methyl salicylate; except for external use; except for internal use when present as an excipient in medicines containing 1.04% or less per dose form

1280

Methyl trienolone

1281

Methyldopa

1282

Methylene blue; for injection

1283

Methylergometrine

1284

Methylhexanamine (1,3-dimethylamylamine (DMAA)); except when present as an unmodified, naturally occurring substance

1285

Methylnaltrexone

1286

Methylpentynol

1287

Methylphenidate

1288

Methylphenobarbital

1289

Methylprednisolone

1290

Methyltestosterone

1291

Methylthiouracil

1292

Methyprylon

1293

Methysergide

1294

Metoclopramide; except when specified elsewhere in this schedule

1295

Metolazone

1296

Metoprolol

1297

Metribolone

1298

Metrifonate

1299

Metronidazole

1300

Metyrapone

1301

Mexiletine

1302

Mezlocillin

1303

Mianserin

1304

Mibefradil

1305

Mibolerone

1306

Micafungin

1307

Miconazole; except when specified elsewhere in this schedule

1308

Midazolam

1309

Midodrine

1310

Mifepristone

1311

Migalastat

1312

Miglitol

1313

Miglustat

1314

Milnacipran

1315

Milrinone

1316

Minocycline

1317

Minoxidil; except for dermal use in medicines containing 5% or less

1318

Mirabegron

1319

Mirtazapine

1320

Misoprostol

1321

Mitobronitol

1322

Mitomycin

1323

Mitoxantrone

1324

Mitragyna speciosa

1325

Mitragynine

1326

Mivacurium

1327

Moclobemide

1328

Modafinil

1329

Molgramostim

1330

Molindone

1331

Molracetam

1332

Mometasone; except when specified elsewhere in this schedule

1333

Monobenzone

1334

Monoclonal antibodies; except in pregnancy test kits

1335

Montelukast

1336

Moperone

1337

Morazone

1338

Moricizine

1339

Morphine; except when specified elsewhere in this schedule

1340

Motrazepam

1341

Motretinide

1342

Moxifloxacin

1343

Mumps vaccine

1344

Mupirocin

1345

Muraglitazar

1346

Muromonab

1347

Mustine

1348

Mycophenolic acid

1349

Nabilone

1350

Nabumetone

1351

Nadolol

1352

Nadroparin

1353

Nafarelin

1354

Naftidrofuryl

1355

Nalbuphine

1356

Nalidixic acid

1357

Nalmefene

1358

Nalorphine

1359

Naloxegol

1360

Naloxone; except when provided as part of an approved emergency kit for the treatment of opioid overdose

1361

Naltrexone

1362

Nandrolone

1363

Naproxen; except when specified elsewhere in this schedule

1364

Naratriptan

1365

Natalizumab

1366

Natamycin

1367

Nateglinide

1368

Nebacumab

1369

Nebivolol

1370

Nebracetam (and its stereoisomers)

1371

Nedocromil

1372

Nefazodone

1373

Nefiracetam

1374

Nefopam

1375

Nelfinavir

1376

Neomycin

1377

Neostigmine

1378

Nepafenac

1379

Nepidermin

1380

Nerium oleander

1381

Nesiritide

1382

Netilmicin

1383

Netupitant

1384

Nevirapine

1385

Nialamide

1386

Nicardipine

1387

Nicergoline

1388

Nicofuranose

1389

Nicoracetam

1390

Nicorandil

1391

Nicotine; except when specified elsewhere in the schedule; except in preparations for oromucosal or transdermal absorption; for nasal use except when sold from a smoking cessation clinic run under the auspices of a registered medical practitioner; in medicines other than for smoking cessation

1392

Nicotinic acid except nicotinamide; except when specified elsewhere in this schedule

1393

Nicoumalone

1394

Nifedipine

1395

Nifenazone

1396

Nikethamide

1397

Nilotinib

1398

Nilutamide

1399

Nimesulide

1400

Nimetazepam

1401

Nimodipine

1402

Nimorazole

1403

Nintedanib

1404

Niridazole

1405

Nisoldipine

1406

Nitazoxanide

1407

Nitisinone

1408

Nitrazepam

1409

Nitrendipine

1410

Nitric oxide

1411

Nitrofurantoin

1412

Nitrofurazone

1413

Nitrous oxide; when supplied for inhalation

1414

Nitroxoline

1415

Nivolumab

1416

Nizatidine; except when specified elsewhere in this schedule

1417

Nomegestrol

1418

Nomifensine

1419

Noopept (and its stereoisomers)

1420

Noradrenaline

1421

Norandrostenolone

1422

Norbolethone

1423

Norclostebol

1424

Nordazepam

1425

Norelgestromin

1426

Norethandrolone

1427

Norethisterone; except when supplied for oral contraception to women who meet the clinical and eligibility criteria of the Pharmacy Council and the Pharmaceutical Society of New Zealand Incorporated approved training programme on oral contraception, when sold in the manufacturer’s original pack that has received the consent of the Minister or Director-General to their distribution as medicines, containing not more than 6 months’ supply by a registered pharmacist who has successfully completed the approved training programme

1428

Norfloxacin

1429

Norgestrel

1430

Noribogaine

1431

Normethandrone

1432

Nortriptyline

1433

Noxiptyline

1434

Nusinersen

1435

Nux vomica; except in medicines containing 1 milligram or less per litre or per kilogram of strychnine

1436

Nystatin; except when specified elsewhere in this schedule

1437

Obinutuzumab

1438

Ocrelizumab

1439

Ocriplasmin

1440

Octamylamine

1441

Octatropine

1442

Octreotide

1443

Octyl nitrite

1444

Oestradiol; except in medicines containing 10 micrograms or less per litre or per kilogram

1445

Oestriol

1446

Oestrogens

1447

Oestrone; except in medicines containing 1 milligram or less per litre or per kilogram

1448

Ofatumumab

1449

Ofloxacin

1450

Olanzapine

1451

Olaparib

1452

Oleandomycin

1453

Oleandrin

1454

Olmesartan

1455

Olodaterol

1456

Olopatadine

1457

Olsalazine

1458

Omalizumab

1459

Ombitasvir

1460

Omeprazole; except when specified elsewhere in this schedule

1461

Ondansetron

1462

Opipramol

1463

Opium; except when specified elsewhere in this schedule

1464

Orciprenaline

1465

Orlistat; except in medicines for weight control containing 120 milligrams or less per dose form

1466

Ornidazole

1467

Ornipressin

1468

Orphenadrine

1469

Orthopterin

1470

Oseltamivir; except when specified elsewhere in this schedule

1471

Osimertinib

1472

Otilonium bromide

1473

Ouabain

1474

Ovandrotone

1475

Oxabolone

1476

Oxacillin

1477

Oxaliplatin

1478

Oxandrolone

1479

Oxaprozin

1480

Oxazepam

1481

Oxazolam

1482

Oxcarbazepine

1483

Oxedrine; except in medicines containing 30 milligrams or less per recommended daily dose

1484

Oxetacaine; except for internal use

1485

Oxiconazole; except when specified elsewhere in this schedule

1486

Oxiracetam (and its stereoisomers)

1487

Oxitropium

1488

Oxolamine

1489

Oxolinic acid

1490

Oxpentifylline

1491

Oxprenolol

1492

Oxybuprocaine; except when used in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board

1493

Oxybutynin

1494

Oxycodone

1495

Oxymesterone

1496

Oxymetholone

1497

Oxyphenbutazone

1498

Oxyphencyclimine

1499

Oxyphenisatin; at all strengths

1500

Oxyphenonium

1501

Oxytetracycline

1502

Oxytocin; except in medicines containing 1 microgram or less per litre or per kilogram

1503

Paclitaxel

1504

Palbociclib

1505

Palifermin

1506

Paliperidone

1507

Palivizumab

1508

Palonosetron

1509

Pamaquin

1510

Pamidronic acid

1511

Pancreatic enzymes; except in medicines containing 20 000 BP units or less of lipase activity

1512

Pancuronium

1513

Panitumumab

1514

Panobinostat

1515

Pantoprazole; except when specified elsewhere in this schedule

1516

Papaveretum

1517

Papaverine; for injection

1518

Paracetamol; except when specified elsewhere in this schedule

1519

Paraldehyde

1520

Paramethadione

1521

Paramethasone

1522

Parecoxib

1523

Paricalcitol

1524

Paritabprevir

1525

Paromomycin

1526

Paroxetine

1527

Pasireotide

1528

Patent blue V; for injection when used in diagnostic procedures

1529

Patiromer sorbitex calcium

1530

Pazopanib

1531

Pecazine

1532

Pefloxacin

1533

Pegaptanib

1534

Pegaspargase

1535

Pegfilgrastim

1536

Peginterferon

1537

Peginterferon beta-1a

1538

Pegvisomant

1539

Pembrolizumab

1540

Pemetrexed

1541

Pemoline

1542

Pempidine

1543

Penbutolol

1544

Penciclovir; except when specified elsewhere in this schedule

1545

Penicillamine

1546

Pentaerythrityl tetranitrate

1547

Pentagastrin

1548

Pentamethonium

1549

Pentamidine

1550

Pentazocine

1551

Penthienate

1552

Pentolinium

1553

Pentosan polysulfate sodium

1554

Pentostatin

1555

Pentoxifylline

1556

Peramivir

1557

Perampanel

1558

Pergolide

1559

Perhexiline

1560

Pericyazine

1561

Perindopril

1562

Permethrin; except in medicines containing 5% or less

1563

Perphenazine

1564

Pertussis antigen

1565

Pertussis (whooping cough) vaccine

1566

Pertuzumab

1567

Pethidine

1568

Phenacemide

1569

Phenacetin; except when present as an excipient

1570

Phenaglycodol

1571

Phenazone; except for external use

1572

Phenazopyridine

1573

Phenelzine

1574

Pheneticillin

1575

Phenformin

1576

Phenglutarimide

1577

Phenibut

1578

Phenindione

1579

Pheniramine; except when specified elsewhere in this schedule

1580

Phenisatin

1581

Phenobarbital

1582

Phenol; for injection

1583

Phenolphthalein

1584

Phenoperidine

1585

Phenoxybenzamine

1586

Phenoxymethylpenicillin

1587

Phensuximide

1588

Phentermine

1589

Phenthimentonium

1590

Phentolamine

1591

Phenylbutazone

1592

Phenylephrine; except when specified elsewhere in this schedule

1593

Phenylpropanolamine

1594

Phenyltoloxamine

1595

Phenytoin

1596

Phleum pratense extract

1597

Pholcodine; except when specified elsewhere in this schedule

1598

Phosphodiesterase type 5 inhibitors; except when present as an unmodified, naturally occurring substance; except when specified elsewhere in this schedule

1599

Phthalylsulfathiazole

1600

Physostigmine

1601

Pibrentasvir

1602

Picibanil

1603

Picric acid

1604

Picrotoxin

1605

Pilocarpine; except in medicines containing 0.025% or less

1606

Pimecrolimus

1607

Pimozide

1608

Pinacidil

1609

Pinazepam

1610

Pindolol

1611

Pioglitazone

1612

Pipecuronium

1613

Pipemidic acid

1614

Pipenzolate

1615

Piperacetam

1616

Piperacillin

1617

Piperidine

1618

Piperidolate

1619

Pipobroman

1620

Pipothiazine

1621

Pipradrol

1622

Piracetam

1623

Pirbuterol

1624

Pirenoxine

1625

Pirenzepine

1626

Piretanide

1627

Pirfenidone

1628

Piroxicam; except for external use

1629

Pirprofen

1630

Pitavastatin

1631

Pituitary hormones

1632

Pivampicillin

1633

Pizotifen

1634

Plerixafor

1635

Plicamycin

1636

Pneumococcal vaccine; except in oral vaccines for the prophylaxis of bacterial complications of colds

1637

Podophyllotoxin; for internal use; for external use for the treatment of anogenital warts; for other external use in medicines containing more than 1%; except in medicines containing 1 milligram or less of podophyllin per litre or per kilogram

1638

Podophyllum emodi; for internal use; for external use for the treatment of anogenital warts; for other external use in medicines containing more than 20% of podophyllin; except in medicines containing 1 milligram or less of podophyllin per litre or per kilogram

1639

Podophyllum peltatum; for internal use; for external use for the treatment of anogenital warts; for other external use in medicines containing more than 20% of podophyllin; except in medicines containing 1 milligram or less of podophyllin per litre or per kilogram

1640

Polidexide

1641

Poliomyelitis vaccine

1642

Polyacrylamide; in injections or implants for tissue augmentation or cosmetic use

1643

Polyestradiol

1644

Polylactic acid; in injections or implants for tissue augmentation or cosmetic use

1645

Polymyxin

1646

Polysulfated glycosaminoglycans; for injection except in intraocular viscoelastic products

1647

Polythiazide

1648

Pomalidomide

1649

Ponatinib

1650

Poractant alfa

1651

Posaconazole

1652

Potassium bromide

1653

Potassium perchlorate

1654

Practolol

1655

Pradofloxacin

1656

Pralatrexate

1657

Pralidoxime

1658

Pralmorelin

1659

Pramipexole

1660

Pramiracetam

1661

Pramocaine

1662

Prampine

1663

Prasterone

1664

Prasugrel

1665

Pravastatin

1666

Prazepam

1667

Praziquantel

1668

Prazosin

1669

Prednisolone

1670

Prednisone

1671

Pregabalin

1672

Pregnenolone

1673

Prenalterol

1674

Prenylamine

1675

Prilocaine; for injection except when used as a local anaesthetic in practice by a dental therapist or an oral therapist registered with the Dental Council; except when specified elsewhere in this schedule

1676

Primaquine

1677

Primidone

1678

Probenecid

1679

Probucol

1680

Procainamide

1681

Procaine

1682

Procaine penicillin

1683

Procarbazine

1684

Prochlorperazine; except when specified elsewhere in this schedule; except when sold for the treatment of nausea associated with emergency contraception by pharmacists or nurses accredited to sell levonorgestrel for emergency contraception

1685

Procyclidine; except for dermal use in medicines containing 5% or less

1686

Progesterone; except in medicines containing 1 milligram or less per litre or per kilogram

1687

Progestogens

1688

Proglumide

1689

Proguanil

1690

Prolintane

1691

Promazine

1692

Promethazine; except when specified elsewhere in this schedule

1693

Promoxolane

1694

Propafenone

1695

Propamidine; except for ophthalmic use

1696

Propanidid

1697

Propantheline

1698

Propetandrol

1699

Propionibacterium acnes

1700

Propofol

1701

Propranolol; except in medicines containing 1 milligram or less per litre or per kilogram

1702

Propylthiouracil

1703

Propyphenazone

1704

Proquazone

1705

Proscillaridin

1706

Prostaglandins

1707

Protamine

1708

Prothionamide

1709

Prothipendyl

1710

Protirelin

1711

Protoveratrines

1712

Protriptyline

1713

Proxymetacaine; except when used in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board

1714

Prucalopride

1715

Pseudoephedrine

1716

Pulmonaria spp; at all strengths

1717

Pyrazinamide

1718

Pyridinolcarbamate

1719

Pyridostigmine

1720

Pyridoxal; except in medicines containing 200 milligrams or less per recommended daily dose

1721

Pyridoxamine; except in medicines containing 200 milligrams or less per recommended daily dose

1722

Pyridoxine; except in medicines containing 200 milligrams or less per recommended daily dose

1723

Pyrimethamine

1724

Pyrvinium

1725

Quazepam

1726

Quetiapine

1727

Quinagolide

1728

Quinapril

1729

Quinbolone

1730

Quinethazone

1731

Quinidine

1732

Quinine; except in medicines containing 50 milligrams or less per recommended daily dose

1733

Quinisocaine

1734

Quinupristin

1735

Rabeprazole

1736

Rabies vaccine

1737

Raloxifene

1738

Raltegravir

1739

Raltitrexed

1740

Ramipril

1741

Ramucirumab

1742

Ranibizumab

1743

Ranitidine; except when specified elsewhere in this schedule

1744

Ranolazine

1745

Rapacuronium

1746

Rasagiline

1747

Rasburicase

1748

Rauwolfia serpentina

1749

Rauwolfia vomitoria

1750

Razoxane

1751

Reboxetine

1752

Recombinant human epidermal growth factor

1753

Recombinant varicella zoster virus glycoprotein E antigen

1754

Regorafenib

1755

Remestemcel-L

1756

Remifentanil

1757

Remoxipride

1758

Repaglinide

1759

Reserpine

1760

Reslizumab

1761

Retapamulin

1762

Reteplase

1763

Retigabine

1764

Ribavirin

1765

Ribociclib

1766

Ridaforolimus

1767

Rifabutin

1768

Rifampicin

1769

Rifamycin

1770

Rifapentine

1771

Rifaximin

1772

Rilmazafone

1773

Rilpivirine

1774

Riluzole

1775

Rimexolone

1776

Rimiterol

1777

Rimonabant

1778

Riociguat

1779

Risedronic acid

1780

Risperidone

1781

Ritodrine

1782

Ritonavir

1783

Rituximab

1784

Rivaroxaban

1785

Rivastigmine

1786

Rizatriptan; except when specified elsewhere in this schedule

1787

Rocuronium

1788

Rofecoxib

1789

Roflumilast

1790

Rolipram (and its stereoisomers)

1791

Rolitetracycline

1792

Rolziracetam

1793

Romidepsin

1794

Romiplostim

1795

Ropinirole

1796

Ropivacaine

1797

Rosiglitazone

1798

Rosoxacin

1799

Rosuvastatin

1800

Rotavirus vaccine

1801

Rotigotine

1802

Roxibolone

1803

Roxithromycin

1804

Rubella vaccine

1805

Ruboxistaurin

1806

Rufinamide

1807

Rupatadine

1808

Ruxolitnib

1809

Sabadilla; except in preparations containing 10 milligrams or less of total alkaloids of schoenocaulon officinale per litre or per kilogram

1810

Sacubitril

1811

Safrole; for internal use except in medicines containing 0.1% or less

1812

Salbutamol

1813

Salcatonin

1814

Salmeterol

1815

Sapropterin

1816

Saquinavir

1817

Sargramostim

1818

Sarilumab

1819

Saxagliptin

1820

Schoenocaulon officinale; except in preparations containing 10 milligrams or less of total alkaloids of schoenocaulon officinale per litre or per kilogram

1821

Scopolia carniolica

1822

Sebelipase alfa

1823

Secbutabarbital

1824

Secobarbital

1825

Secukinumab

1826

Selective androgen receptor modulators

1827

Seletracetam (and its stereoisomers)

1828

Selegiline

1829

Selenium; except when specified elsewhere in this schedule; except for oral use in medicines containing 150 micrograms or less per recommended daily dose

1830

Selexipag

1831

Serelaxin

1832

Sermorelin

1833

Sertindole

1834

Sertraline

1835

Serum, dried human

1836

Sevelamer

1837

Sevoflurane

1838

Sex hormones and all substances having sex hormone activity

1839

Sialoepoetin

1840

Sibutramine

1841

Silandrone

1842

Sildenafil and its structural analogues; except sildenafil in medicines for oral use containing 100 milligrams or less per dose unit when sold in the manufacturer’s original pack containing not more than 12 solid dosage units for the treatment of erectile dysfunction in males aged 35–70 years by a registered pharmacist who has successfully completed a training programme endorsed by the Pharmaceutical Society of New Zealand Incorporated

1843

Silicones; for injection

1844

Silodosin

1845

Siltuximab

1846

Silver sulfadiazine; except for external use in packs containing 50 grams or less

1847

Simeprevir

1848

Simvastatin

1849

Sirolimus

1850

Sisomicin

1851

Sitagliptin

1852

Sitaxentan

1853

Sodium bromide

1854

Sodium cellulose phosphate; for internal use

1855

Sodium cromoglycate; except for nasal and ophthalmic use

1856

Sodium morrhuate; for injection

1857

Sodium nitroprusside

1858

Sodium phenylbutyrate

1859

Sodium phosphate; in oral laxative preparations

1860

Sodium polystyrene sulphonate

1861

Sodium tetradecyl sulphate; for injection

1862

Sodium zirconium cyclosilicate

1863

Sofosbuvir

1864

Solasadine

1865

Solifenacin

1866

Somatostatin

1867

Somatropin

1868

Sonidegib

1869

Sontoquine

1870

Sorafenib

1871

Sotalol

1872

Sparfloxacin

1873

Sparteine

1874

Spectinomycin

1875

Spiramycin

1876

Spirapril

1877

Spironolactone

1878

Stanolone

1879

Stanozolol

1880

Staphylococcus aureus vaccine; except in oral vaccines for the prophylaxis of bacterial complications of colds

1881

Stavudine

1882

Stenbolone

1883

Steroid hormones

1884

Stilboestrol

1885

Stiripentol

1886

Stramonium; except for oral use when specified elsewhere in this schedule; except datura stramonium or datura tatula for smoking or burning

1887

Streptococcus beta-haemolyticus vaccine; except in oral vaccines for the prophylaxis of bacterial complications of colds

1888

Streptodornase

1889

Streptokinase

1890

Streptomycin

1891

Streptozocin

1892

Strontium ranelate

1893

Strophanthins

1894

Strophanthus spp

1895

Strychnos spp; except in medicines containing 1 milligram or less per litre or per kilogram of strychnine

1896

Styramate

1897

Succimer

1898

Sufentanil

1899

Sugammadex

1900

Sulbactam

1901

Sulconazole; except for dermal use

1902

Sulfacetamide; except for ophthalmic use in medicines containing 10% or less

1903

Sulfadiazine; except silver sulfadiazine for external use in pack sizes of 50 grams or less

1904

Sulfadimethoxine

1905

Sulfadimidine

1906

Sulfadoxine

1907

Sulfafurazole

1908

Sulfaguanidine

1909

Sulfamerazine

1910

Sulfamethizole

1911

Sulfamethoxazole

1912

Sulfamethoxydiazine

1913

Sulfamethoxypyridazine

1914

Sulfametrole

1915

Sulfamonomethoxine

1916

Sulfamoxole

1917

Sulfaphenazole

1918

Sulfapyridine

1919

Sulfasalazine

1920

Sulfathiazole

1921

Sulfatroxazole

1922

Sulfinpyrazone

1923

Sulfomyxin

1924

Sulfonmethane

1925

Sulindac

1926

Sultamicillin

1927

Sulthiame

1928

Sumatriptan; except when specified elsewhere in this schedule

1929

Sunifiram

1930

Sunitinib

1931

Suprofen

1932

Suvorexant

1933

Sutilains

1934

Suxamethonium

1935

Suxethonium

1936

T cell receptor antibody

1937

Tacrine

1938

Tacrolimus

1939

Tadalafil and its structural analogues

1940

Tafenoquine succinate

1941

Tafluprost

1942

Taliglucerase alfa

1943

Talimogene laherparepvec

1944

Tamoxifen

1945

Tamsulosin

1946

Tanacetum vulgare; except in medicines containing 0.8% or less of oil of tansy

1947

Tapentadol

1948

Tasonermin

1949

Tazarotene

1950

Tazobactam

1951

Teduglutide

1952

Tegafur

1953

Tegaserod

1954

Teicoplanin

1955

Telaprevir

1956

Telbivudine

1957

Telithromycin

1958

Telmisartan

1959

Telotristat ethyl

1960

Temazepam

1961

Temozolomide

1962

Temsirolimus

1963

Tenecteplase

1964

Teniposide

1965

Tenofovir

1966

Tenoxicam

1967

Terazosin

1968

Terbinafine; except when specified elsewhere in this schedule

1969

Terbutaline

1970

Terfenadine

1971

Teriflunomide

1972

Teriparatide

1973

Terlipressin

1974

Terodiline

1975

Teropterin

1976

Tesamorelin

1977

Testolactone

1978

Testosterone; except in medicines containing 1 milligram or less per litre or per kilogram

1979

Tetanus antitoxin

1980

Tetanus toxoid

1981

Tetanus vaccine

1982

Tetrabenazine

1983

Tetracosactrin

1984

Tetracycline

1985

Tetraethylammonium

1986

Tetrahydrocannabinol

1987

Tetrazepam

1988

Tetroxoprim

1989

Thalidomide

1990

Thenyldiamine

1991

Theophylline; except when specified elsewhere in this schedule

1992

Thevetia peruviana

1993

Thevetin

1994

Thiambutosine

1995

Thiazosulfone

1996

Thiethylperazine

1997

Thioacetazone

1998

Thiocarlide

1999

Thioguanine

2000

Thiomesterone

2001

Thiopentone

2002

Thiopropazate

2003

Thioproperazine

2004

Thioridazine

2005

Thiotepa

2006

Thiothixene

2007

Thiouracil

2008

Thiourea; except in medicines containing 0.1% or less

2009

Thymosin beta-4

2010

Thymoxamine

2011

Thyroid

2012

Thyrotrophin

2013

Thyrotrophin-releasing factor

2014

Thyroxine; except in medicines containing 10 micrograms or less per litre or per kilogram

2015

Tiagabine

2016

Tianeptine

2017

Tiaprofenic acid

2018

Tiaramide

2019

Tibolone

2020

Ticagrelor

2021

Ticarcillin

2022

Ticlopidine

2023

Tiemonium

2024

Tienilic acid

2025

Tigecycline

2026

Tigloidine

2027

Tiletamine

2028

Tilidine

2029

Tiludronic acid

2030

Timbetasin

2031

Timolol

2032

Tinidazole

2033

Tinzaparin

2034

Tioconazole; except when specified elsewhere in this schedule

2035

Tiotropium

2036

Tipepidine

2037

Tipiracil

2038

Tiprinavir

2039

Tirilazad

2040

Tirofiban

2041

Tizanidine

2042

Tobramycin

2043

Tocainide

2044

Tocilizumab

2045

Tofacitinib

2046

Tolazamide

2047

Tolazoline

2048

Tolbutamide

2049

Tolcapone

2050

Tolfenamic acid

2051

Tolmetin

2052

Tolonium

2053

Tolpropamine

2054

Tolrestat

2055

Tolterodine

2056

Tolvaptan

2057

Topiramate

2058

Topotecan

2059

Torasemide

2060

Toremifene

2061

Toxoids; for injection

2062

Tramadol

2063

Trametinib dimethyl sulfoxide

2064

Trandolapril

2065

Tranexamic acid

2066

Tranylcypromine

2067

Trastuzumab

2068

Trastuzumab emtansine

2069

Travoprost

2070

Trazodone

2071

Trenbolone

2072

Treosulphan

2073

Treprostinil

2074

Trestolone

2075

Tretamine

2076

Tretinoin

2077

Triacetyloleandomycin

2078

Triamcinolone; except when specified elsewhere in this schedule

2079

Triamterene

2080

Triaziquone

2081

Triazolam

2082

Trichlormethiazide

2083

Trichloroacetic acid; except for external use in medicines containing 12.5% or less for the treatment of warts other than anogenital warts

2084

Trichloroethylene

2085

Trichodesma africana; at all strengths

2086

Triclofos

2087

Tricyclamol

2088

Tridihexethyl

2089

Trientine

2090

Trifluoperazine

2091

Trifluperidol

2092

Triflupromazine

2093

Trifluridine

2094

Trimeprazine; except when specified elsewhere in this schedule

2095

Trimetaphan

2096

Trimethoprim; except in medicines for oral use containing 300 milligrams or less per dose unit when sold in a pack of 3 solid dosage units to a woman aged 16–65 years for the treatment of an uncomplicated urinary tract infection by a registered pharmacist who has successfully completed the New Zealand College of Pharmacists’ training in the treatment of urinary tract infections

2097

Trimipramine

2098

Trimustine

2099

Trinitrophenol

2100

Trioxysalen

2101

Triparanol; at all strengths

2102

Triple antigen vaccine

2103

Triprolidine; except when specified elsewhere in this schedule

2104

Triptorelin

2105

Troglitazone

2106

Trometamol; for injection in medicines containing more than 3%

2107

Tropicamide; except when used in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board

2108

Tropisetron

2109

Trovafloxacin

2110

Troxidone

2111

Tryptophan; except in medicines containing 100 milligrams or less per recommended daily dose; except in parenteral nutrition replacement preparations

2112

Tuberculin

2113

Tuberculosis vaccine

2114

Tubocurarine

2115

Tulobuterol

2116

Typhoid vaccine

2117

Ulipristal

2118

Umeclidinium bromide

2119

Unoprostone

2120

Uracil

2121

Urapidil

2122

Urethane

2123

Urofollitropin

2124

Urokinase

2125

Ursodeoxycholic acid

2126

Ustekinumab

2127

Vaccines; except when specified elsewhere in this schedule

2128

Vaccinia virus vaccine

2129

Valaciclovir

2130

Valdecoxib

2131

Valganciclovir

2132

Valnoctamide

2133

Valproic acid

2134

Valsartan

2135

Vancomycin

2136

Vandetanib

2137

Vardenafil and its structural analogues

2138

Varenicline

2139

Varicella vaccine; except when administered for the prevention of herpes zoster (shingles) to a person 50 years of age or over by a registered pharmacist who has successfully completed a vaccinator training course approved by the Ministry of Health and who is complying with the immunisation standards of the Ministry of Health

2140

Vasopressin

2141

Vecuronium

2142

Vedolizumab

2143

Velaglucerase alfa

2144

Velpatasvir

2145

Vemurafenib

2146

Venetoclax

2147

Venlafaxine

2148

Verapamil

2149

Veratrum spp

2150

Vernakalant

2151

Verteporfin

2152

Veruprevir

2153

Vidarabine

2154

Vigabatrin

2155

Vilanterol

2156

Vildagliptin

2157

Viloxazine

2158

Vinblastine

2159

Vincamine

2160

Vincristine

2161

Vindesine

2162

Vinflunine

2163

Vinorelbine

2164

Vinyl ether

2165

Virginiamycin

2166

Vismodegib

2167

Visnadine

2168

Vitamin A; except for internal use in medicines containing 3 milligrams or less of retinol equivalents per recommended daily dose; except in parenteral nutrition replacement preparations; except for external use in medicines containing 1% or less

2169

Vitamin D; except for external use; except for internal use in medicines containing 25 micrograms or less per recommended daily dose; except in parenteral nutrition replacement preparations

2170

Vorapaxar

2171

Voriconazole

2172

Vorinostat

2173

Vortioxetine

2174

Warfarin

2175

Xamoterol

2176

Xanthinol nicotinate

2177

Ximelagatran

2178

Xipamide

2179

Yellow fever vaccine

2180

Yohimbine

2181

Zafirlukast

2182

Zalcitabine

2183

Zaleplon

2184

Zanamivir

2185

Zidovudine

2186

Zimeldine

2187

Zinc; except for internal use in medicines containing 25 milligrams or less per recommended daily dose; except for internal use in medicines containing 50 milligrams or less and more than 25 milligrams per recommended daily dose in packs that have received the consent of the Minister or the Director-General to their distribution as general sale medicines, when sold in the manufacturer’s original pack and when labelled with a statement that the product may be dangerous if taken in large amounts or for long periods; except for external use when in medicines containing 5% or less; except in parenteral nutrition replacement preparations

2188

Ziprasidone

2189

Zoledronic acid

2190

Zolmitriptan; except when specified elsewhere in this schedule

2191

Zolpidem

2192

Zonisamide

2193

Zopiclone

2194

Zoster immunoglobulin, human

2195

Zoxazolamine

2196

Zuclopenthixol

Part 2 Restricted medicines

1

Adrenaline; in medicines containing 1% or less except in medicines for injection containing 0.02% or less

2

Alclometasone; for dermal use in medicines containing 0.05% or less and in packs containing not more than 30 grams that have received the consent of the Minister or the Director-General to their distribution as restricted medicines, when sold in the manufacturer’s original pack

3

Aminophylline; for oral use in liquid form in medicines containing 2% or less

4

Amorolfine; for external use in medicines containing more than 0.25%

5

Aspirin; in slow-release forms; in enteric coated forms containing more than 300 milligrams per dose form

6

Azatadine; for oral use in adults and children over 2 years of age

7

Azelastine; in medicines for ophthalmic use containing 0.05% or less

8

Brompheniramine; for oral use in medicines for adults or children over 2 years of age other than in medicines used for the treatment of insomnia; for oral use for the treatment of insomnia when sold in the manufacturer’s original pack containing not more than 10 dosage units

9

Buclizine; for oral use

10

Butoconazole; for vaginal use

11

Chloramphenicol; for ophthalmic use; except when sold in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board

12

Chlorbutol; except when specified elsewhere in this schedule

13

Chlorpheniramine; for oral use in medicines for adults or children over 2 years of age other than in medicines used for the treatment of insomnia; for oral use for the treatment of insomnia when sold in the manufacturer’s original pack containing not more than 10 dosage units

14

Ciclopirox; for external use in medicines containing more than 2%; in preparations for application to the nails containing more than 8%

15

Cimetidine; in medicines for the symptomatic relief of heartburn, dyspepsia, and hyperacidity or to be used on the recommendation of a registered medical practitioner, when sold in the manufacturer’s original pack containing not more than 14 days’ supply

16

Clemastine; for oral use

17

Clobetasone; for dermal use in medicines containing 0.05% or less and in packs containing not more than 30 grams that have received the consent of the Minister or the Director-General to their distribution as restricted medicines, when sold in the manufacturer’s original pack

18

Clotrimazole; for vaginal use

19

Codeine; in medicines for oral use containing not more than 15 milligrams of codeine per solid dosage unit or per dose of liquid with a maximum daily dose not exceeding 100 milligrams of codeine, when combined with 1 or more active ingredients in such a way that the substance cannot be recovered by readily applicable means or in a yield that would constitute a risk to health, for use as an analgesic and when sold in a pack of not more than 5 days’ supply, approved by the Minister or the Director-General for distribution as a restricted medicine

20

Cyclizine; for oral use other than in medicines used for the treatment of insomnia when sold in the manufacturer’s original pack containing not more than 6 dosage units; for oral use in medicines used for the treatment of insomnia when sold in the manufacturer’s original pack containing not more than 10 dosage units

21

Cyproheptadine; for oral use

22

Dexchlorpheniramine; for oral use in medicines for adults or children over 2 years of age other than in medicines used for the treatment of insomnia; for oral use for the treatment of insomnia when sold in the manufacturer’s original pack containing not more than 10 dosage units

23

Di-iodohydroxy quinoline; for vaginal use

24

Diclofenac; in solid dose form in medicines containing 25 milligrams or less and more than 12.5 milligrams per dose form in packs containing not more than 30 tablets or capsules

25

Dimenhydrinate; for oral use in medicines for adults and children over 2 years of age; except when specified elsewhere in this schedule

26

Dimethindene; for oral use

27

Diphenhydramine; for oral use in medicines for adults or children over 2 years of age other than in medicines used for the treatment of insomnia; for oral use for the treatment of insomnia when sold in the manufacturer’s original pack containing not more than 10 dosage units

28

Dithranol

29

Doxylamine; for oral use in medicines for adults or children over 2 years of age other than in medicines used for the treatment of insomnia; for oral use for the treatment of insomnia when sold in the manufacturer’s original pack containing not more than 10 dosage units

30

Econazole; for vaginal use

31

Erythrityl tetranitrate

32

Famciclovir; in divided solid dosage forms for oral use containing 500 milligrams or less for the treatment of recurrent herpes labialis when sold in the manufacturer’s original pack containing up to 3 dosage units

33

Flavoxate

34

Fluconazole; for oral use in medicines that have received the consent of the Minister or the Director-General to their distribution as restricted medicines, when sold in the manufacturer’s original pack containing 150 milligrams or less as a single dose for the treatment of vaginal candidiasis

35

Fluorides; for external use in liquid form in medicines containing 5.5 grams or less and more than 1 gram per litre or per kilogram and when sold in packs approved by the Minister or the Director-General for distribution as restricted medicines; for external use in non-liquid form in medicines containing 5.5 grams or less and more than 1 gram per litre or per kilogram, except in medicines containing 1.5 grams or less and more than 1 gram per litre or per kilogram; except when supplied to a dental professional registered with the Dental Council

36

Glucagon; except in medicines containing 100 micrograms or less per litre or per kilogram

37

Glyceryl trinitrate; for oral or sublingual use; for rectal use

38

Guaifenesin; for oral use in modified release form with a maximum recommended daily dose of not more than 2.4 grams when sold in the manufacturer’s original pack containing more than 10 days’ supply but not more than 30 days’ supply; except for oral use in modified release form with a maximum recommended daily dose of not more than 2.4 grams when sold in the manufacturer’s original pack containing not more than 10 days’ supply; except for oral use in medicines containing 2% or less or 200 milligrams or less per dose form

39

Haemophilus influenzae vaccine; in oral vaccines for the prophylaxis of bacterial complications of colds

40

Hydrocortisone and hydrocortisone acetate but no other esters of hydrocortisone; for dermal use in medicines containing 1% or less but more than 0.5% by weight of hydrocortisone base with no other active ingredient except an antifungal and in a quantity of 30 grams or less or 30 millilitres or less per container; for dermal use in medicines containing 1% or less but more than 0.5% by weight of hydrocortisone base with no other active ingredient except 5% or less by weight of aciclovir and in a quantity of 2 grams or less or 2 millilitres or less per container in adults and children 12 years of age and older; in rectal medicines containing 1% or less but more than 0.5% by weight of hydrocortisone base and in combination with a local anaesthetic and in a quantity of 35 grams or less per container or up to 12 suppositories per pack

41

Hyoscine butylbromide; for oral use in medicines containing not more than 20 milligrams per dose form and in packs containing not more than 10 tablets or capsules for the relief of muscle spasm of the gastrointestinal tract

42

Ibuprofen; for oral use in tablets or capsules containing up to 400 milligrams per dose form and in packs containing not more than 50 dose units and that have received the consent of the Minister or the Director-General to their distribution as restricted medicines, when sold in the manufacturer’s original pack labelled for use by adults or children over 12 years of age

43

Inositol nicotinate

44

Isoconazole; for vaginal use

45

Ketoprofen; in solid dose form containing 25 milligrams or less per dose form in packs of not more than 30 capsules or tablets

46

Lansoprazole; in divided solid dosage forms for oral use containing 15 milligrams or less with a maximum daily dose of 15 milligrams for the short-term symptomatic relief of gastric reflux-like symptoms in sufferers aged 18 years and over for the relief of heartburn when sold in the manufacturer’s original pack containing not more than 14 dosage units

47

Levonorgestrel; in medicines for use as emergency post-coital contraception when in packs containing not more than 1.5 milligrams

48

Macrogols; in oral preparations for bowel cleansing prior to diagnostic, medical, or surgical procedures

49

Malathion; except for external use in medicines containing 2% or less

50

Mannityl hexanitrate

51

Meclozine; in a pack size of up to 10 dosage units for the treatment of insomnia

52

Mepyramine; for oral use in medicines for adults or children over 2 years of age other than in medicines used for the treatment of insomnia; for oral use for the treatment of insomnia when sold in the manufacturer’s original pack containing not more than 10 dosage units

53

Methdilazine; for oral use

54

Metoclopramide; when compounded with paracetamol in packs of not more than 10 tablets or capsules for the treatment of nausea associated with migraine

55

Miconazole; for the treatment of oral candidiasis; for vaginal use

56

Nicotinic acid except nicotinamide; in medicines containing 250 milligrams or less but more than 100 milligrams per dose form; except in medicines containing 100 milligrams or less per dose form

57

Nicotinyl alcohol; except in medicines containing 100 milligrams or less per dose form

58

Nystatin; for the treatment of oral candidiasis; for vaginal use

59

Orlistat; in medicines for weight control containing 120 milligrams or less per dose form

60

Oseltamivir; in solid dosage forms for oral use containing 75 milligrams in a pack size of up to 10 dosage units for the treatment or prophylaxis of influenza in adults and children aged 13 years and older who have been exposed to the influenza virus

61

Oxiconazole; for vaginal use

62

Pheniramine; for oral use in medicines for adults or children over 2 years of age other than in medicines used for the treatment of insomnia; for oral use for the treatment of insomnia when sold in the manufacturer’s original pack containing not more than 10 dosage units

63

Pneumococcal vaccine; in oral vaccines for the prophylaxis of bacterial complications of colds

64

Podophyllotoxin; for external use for the treatment of warts other than anogenital warts in medicines containing 1% or less and more than 0.5%; except in medicines containing 1 milligram or less of podophyllin per litre or per kilogram

65

Podophyllum emodi; for external use for the treatment of warts other than anogenital warts in medicines containing 20% or less and more than 10% of podophyllin; except in medicines containing 1 milligram or less of podophyllin per litre or per kilogram

66

Podophyllum peltatum; for external use for the treatment of warts other than anogenital warts in medicines containing 20% or less and more than 10% of podophyllin; except in medicines containing 1 milligram or less of podophyllin per litre or per kilogram

67

Prochlorperazine; in packs containing not more than 10 tablets or capsules for the treatment of nausea associated with migraine

68

Promethazine; for oral use in medicines for adults or children over 2 years of age other than in medicines used for the treatment of insomnia; for oral use for the treatment of insomnia when sold in the manufacturer’s original pack containing not more than 10 dosage units

69

Rizatriptan; for oral use in medicines for the acute relief of migraine attacks with or without aura in patients who have a stable, well-established pattern of symptoms, when in wafers containing 5 milligrams or less per wafer and when sold in a pack containing not more than 2 wafers approved by the Minister or the Director-General for distribution as a restricted medicine

70

Salicylic acid; except in medicines for dermal use containing 40% or less

71

Santonin

72

Sodium phosphate; in oral preparations for bowel cleansing prior to diagnostic, medical, or surgical procedures

73

Sodium picosulphate; in oral preparations for bowel cleansing prior to diagnostic, medical, or surgical procedures

74

Staphyloccocus aureus vaccine; in oral vaccines for the prophylaxis of bacterial complications of colds

75

Stramonium; for oral use in liquid form; in solid dose form in medicines containing more than 0.3 milligrams per dose or more than 1.2 milligrams per recommended daily dose

76

Streptococcus beta-haemolyticus vaccine; in oral vaccines for the prophylaxis of bacterial complications of colds

77

Sulfacetamide; for ophthalmic use in medicines containing 10% or less

78

Sumatriptan; for oral use in medicines for the acute relief of migraine attacks with or without aura in patients who have a stable, well-established pattern of symptoms when in tablets containing 50 milligrams or less per tablet and when sold in a pack containing not more than 2 tablets that has received the consent of the Minister or the Director-General to its sale as a restricted medicine

79

Theophylline; in liquid form for oral use in medicines containing 2% or less

80

Tioconazole; for vaginal use

81

Triamcinolone; for buccal use in medicines containing 0.1% or less of triamcinolone acetonide and in pack sizes of 5 grams or less

82

Trimeprazine; for oral use in medicines for adults or children over 2 years of age other than in medicines used for the treatment of insomnia; for oral use for the treatment of insomnia when sold in the manufacturer’s original pack containing not more than 10 dosage units

83

Triprolidine; for oral use in medicines for adults and children over 2 years of age; except when specified elsewhere in this schedule

84

Zolmitriptan; in a pre-filled nasal spray device containing not more than 5 milligrams of zolmitriptan, for the acute relief of migraine attacks with or without aura in patients who have a stable, well-established pattern of symptoms and when sold in a pack of not more than 2 devices approved by the Minister or the Director-General for distribution as a restricted medicine

Part 3 Pharmacy-only medicines

1

8-hydroxyquinoline and its non-halogenated derivatives; in medicines containing more than 1% of such substances; except for hydroxyquinoline sulphate for external use

2

Acetic acid and preparations containing more than 80% of acetic acid (CH₃COOH); excluding its salts and derivatives

3

Acetylcysteine; for oral use in medicines containing more than 1 gram per recommended daily dose

4

Aciclovir; for external use for the treatment of herpes labialis except in medicines containing 5% or less and in tubes containing 10 grams or less

5

Aconitum spp; for oral use in packs containing 0.2 milligrams or less and more than 0.02 milligrams of total alkaloids; for dermal use in concentrations of 0.02% or less and in packs containing 0.2 milligrams or less and more than 0.02 milligrams of total alkaloids

6

Aloes; for internal use; except when obtained solely from the mucilaginous gel of the leaf

7

Aloin

8

Aloxiprin

9

Amethocaine; for external use in medicines containing 10% or less and more than 2%; except in medicines for external use containing 2% or less

10

Amorolfine; in preparations for topical use; except in preparations for the treatment of tinea pedis only or when sold in practice by a podiatrist registered with the Podiatrists Board

11

Antazoline; for ophthalmic use except when sold in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board

12

Atropa belladonna; for external use in medicines containing 0.03% or less of the alkaloids of belladonna; for oral use in liquid form in medicines containing 0.03% or less and 0.3 milligrams or less per dose and not more than 1.2 milligrams per recommended daily dose of the alkaloids of belladonna or in solid dose form in medicines containing 0.3 milligrams or less per dose form and not more than 1.2 milligrams per recommended daily dose of the alkaloids of belladonna

13

Atropine; for oral use in liquid form in medicines containing 0.03% or less and 0.3 milligrams or less per dose and not more than 1.2 milligrams per recommended daily dose or in solid dose form in medicines containing 0.3 milligrams or less per dose form and not more than 1.2 milligrams per recommended daily dose; in medicines containing atropine sulphate for the treatment of organophosphorus poisoning either in packs of not more than 20 dose units containing 0.6 milligrams or less per dose unit or in injections in packs of not more than 5 vials containing 0.6 milligrams per millilitre; except when sold as an antidote in a device designed for self-injection from outlets licensed to sell organophosphorus poisons; except in medicines containing 300 micrograms or less per litre or per kilogram

14

Azelaic acid; for dermal use

15

Azelastine; in preparations for nasal use containing 0.15% azelastine hydrochloride or less; in topical eye preparations containing 0.05% or less

16

Beclomethasone; for the treatment or prophylaxis of allergic rhinitis in adults and children over 12 years of age in aqueous nasal sprays delivering up to 50 micrograms per actuation when the maximum recommended daily dose is no greater than 400 micrograms (200 micrograms per nostril) in a pack containing 200 actuations or less

17

Benzocaine; in preparations for topical use, other than eye drops, containing 10% or less of total anaesthetic substances except in dermal preparations containing 2% or less of total anaesthetic substances; in divided preparations containing 200 milligrams or less of total anaesthetic substances per dosage unit except in lozenges containing 30 milligrams or less of total anaesthetic substances per dosage unit

18

Benzoyl peroxide; for external use in medicines containing more than 5% and not more than 10%; except for medicines for external use containing 5% or less

19

Benzydamine; for external use except for oromucosal or topical use

20

Bephenium

21

Bifonazole; except when specified elsewhere in this schedule; except for dermal use in medicines for tinea pedis only or in shampoos containing 1% or less or when sold in practice by a podiatrist registered with the Podiatrists Board

22

Bilastine; in divided solid dosage forms for oral use containing 20 milligrams or less for the treatment of the symptoms of allergic rhinoconjunctivitis (seasonal and perennial) and urticaria when sold in a pack containing not more than 30 dosage units

23

Bisacodyl

24

Bromhexine

25

Brompheniramine; for oral use in medicines for adults and children over 6 years of age when combined in the same container with 1 or more other therapeutically active ingredients either when in the bedtime dose of a day/night pack containing brompheniramine or when at least 1 of the other active ingredients is a sympathomimetic decongestant

26

Budesonide; for the treatment or prophylaxis of allergic rhinitis in adults and children over 12 years of age in aqueous nasal sprays delivering up to 50 micrograms per actuation and when the maximum recommended daily dose is no greater than 400 micrograms (200 micrograms per nostril) in a pack containing 200 actuations or less

27

Carbetapentane; except in medicines containing 0.5% or less

28

Carbocisteine

29

Cetirizine; for oral use except in divided solid dosage forms for oral use containing 10 milligrams or less of cetirizine hydrochloride per dose form for the treatment of seasonal allergic rhinitis when sold in the manufacturer’s original pack containing not more than 5 days’ supply

30

Chlophedianol

31

Chlorbutol; in medicines containing 5% or less and more than 0.5%; except in medicines containing 0.5% or less

32

Chloroform; in medicines other than for anaesthesia containing more than 0.5%; except in medicines containing 0.5% or less

33

Chlorpheniramine; for oral use in medicines for adults and children over 6 years of age when combined in the same container with 1 or more other therapeutically active ingredients either when in the bedtime dose of a day/night pack containing chlorpheniramine or when at least 1 of the other active ingredients is a sympathomimetic decongestant

34

Ciclopirox; for external use in medicines containing 2% or less except when for the treatment of tinea pedis only or when sold in practice by a podiatrist registered with the Podiatrists Board; in preparations for application to the nails containing 8% or less

35

Cinchocaine; for external use in medicines containing 0.5% or less

36

Cinnamedrine

37

Clotrimazole; for external use except in medicines for tinea pedis only or when sold in practice by a podiatrist registered with the Podiatrists Board

38

Cocaine; in medicines for oral use, containing not more than 0.1% of cocaine, when combined with 1 or more active ingredients in such a way that the substance cannot be recovered by readily applicable means or in a yield that would constitute a risk to health, and when sold in a pack approved by the Minister or the Director-General for distribution as a pharmacy-only medicine

39

Codeine; in medicines for oral use, containing not more than 15 milligrams of codeine per solid dosage unit or per dose of liquid with a maximum daily dose not exceeding 100 milligrams of codeine, when combined with 1 or more active ingredients in such a way that the substance cannot be recovered by readily applicable means or in a yield that would constitute a risk to health, for the treatment of the symptoms of cough and cold and when sold in a pack of not more than 6 days’ supply, approved by the Minister or the Director-General for distribution as a pharmacy-only medicine

40

Colocynth

41

Creosote; except in medicines containing 10% or less

42

Cresols; except in medicines containing 3% or less

43

Datura spp; for oral use in liquid form in medicines containing 0.03% or less and 0.3 milligrams or less per dose and not more than 1.2 milligrams per recommended daily dose of total solanaceous alkaloids; in solid dose form in medicines containing 0.3 milligrams or less per dose form and not more than 1.2 milligrams per recommended daily dose of total solanaceous alkaloids

44

Delphinium staphisagria; except in medicines containing 0.2% or less

45

Desloratadine; for oral use

46

Dexchlorpheniramine; for oral use in medicines for adults and children over 6 years of age when combined in the same container with 1 or more other therapeutically active ingredients either when in the bedtime dose of a day/night pack containing dexchlorpheniramine or when at least 1 of the other active ingredients is a sympathomimetic decongestant

47

Dextromethorphan; in liquid form containing more than 0.25% or in solid dose form containing more than 15 milligrams per dose form when in packs containing not more than 600 milligrams and with a recommended daily dose of not more than 120 milligrams; in medicines for the treatment of the symptoms of cough and cold in children aged 6–12 years; except in liquid form containing 0.25% or less in solid dose form containing 15 milligrams or less per dose form when in packs containing not more than 600 milligrams and with a recommended daily dose of not more than 120 milligrams

48

Dibrompropamidine; for ophthalmic use except when sold in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board

49

Diclofenac; in solid dose form in medicines containing 12.5 milligrams or less per dose form in packs containing not more than 30 tablets or capsules and with a recommended daily dose of not more than 75 milligrams

50

Diphenoxylate; in liquid form containing in each millilitre not more than 0.5 milligrams of diphenoxylate calculated as base and not less than 5 micrograms of atropine sulphate; in solid dose form containing not more than 2.5 milligrams of diphenoxylate calculated as base and not less than 5 micrograms of atropine sulphate

51

Dimenhydrinate; for oral use in a sealed container of not more than 10 tablets or capsules for the prevention or treatment of motion sickness in adults or children over 2 years of age except when sold at a transport terminal or aboard a ship or an aircraft

52

Diphenhydramine; for oral use in medicines for adults and children over 6 years of age when combined in the same container with 1 or more other therapeutically active ingredients either when in the bedtime dose of a day/night pack containing diphenhydramine or when at least 1 of the other active ingredients is a sympathomimetic decongestant; for oral use in a sealed container of not more than 10 tablets or capsules for the prevention or treatment of motion sickness in adults and children over 2 years of age except when sold at a transport terminal or aboard a ship or an aircraft

53

Doxylamine; for oral use in medicines for adults and children over 6 years of age when combined in the same container with 1 or more other therapeutically active ingredients either when in the bedtime dose of a day/night pack containing doxylamine or when at least 1 of the other active ingredients is a sympathomimetic decongestant

54

Duboisia leichhardtii; for oral use in liquid form in medicines containing 0.03% or less and 0.3 milligrams or less per dose and not more than 1.2 milligrams per recommended daily dose of total solanaceous alkaloids; in solid dose form in medicines containing 0.3 milligrams or less per dose form and not more than 1.2 milligrams per recommended daily dose of total solanaceous alkaloids

55

Duboisia myoporides; for oral use in liquid form in medicines containing 0.03% or less and 0.3 milligrams or less per dose and not more than 1.2 milligrams per recommended daily dose of total solanaceous alkaloids; in solid dose form in medicines containing 0.3 milligrams or less per dose form and not more than 1.2 milligrams per recommended daily dose of total solanaceous alkaloids

56

Econazole; for dermal use except in medicines for tinea pedis only or when sold in practice by a podiatrist registered with the Podiatrists Board

57

Esomeprazole; in oral preparations containing 20 milligrams or less per dosage unit for the relief of heartburn and other symptoms of gastro-oesophageal reflux disease, in packs containing not more than 14 days’ supply

58

Etafedrine

59

Ether; in medicines containing more than 10%; except in medicines containing 10% or less

60

Etofenamate; for external use

61

Famotidine; for the symptomatic relief of heartburn, dyspepsia, and hyperacidity or to be used on the recommendation of a registered medical practitioner, when sold in the manufacturer’s original pack containing not more than 14 days’ supply

62

Felbinac; for external use

63

Fexofenadine; for oral use except for the treatment of seasonal allergic rhinitis in adults and children 12 years of age and over when in capsules containing 60 milligrams or less of fexofenadine hydrochloride or in tablets containing 120 milligrams or less of fexofenadine hydrochloride with a maximum daily dose of 120 milligrams when sold in the manufacturer’s original pack containing 10 dosage units or less and not more than 5 days’ supply

64

Fluorides; for internal use in medicines containing 0.5 milligrams or less per dose unit; except in parenteral nutrition replacement preparations; for external use in liquid form in medicines containing 1 gram or less per litre or per kilogram and when sold in packs approved by the Minister or the Director-General for distribution as pharmacy-only medicines except in medicines containing 220 milligrams or less per litre or per kilogram and in packs containing not more than 120 milligrams of total fluoride; except when supplied to any dental professional registered with the Dental Council; except in medicines containing 15 milligrams or less per litre or per kilogram

65

Flurbiprofen; in locally acting oromucosal preparations containing 10 milligrams or less per dosage unit

66

Fluticasone; for the treatment or prophylaxis of allergic rhinitis in adults and children over 12 years of age when in aqueous nasal sprays delivering up to 50 micrograms per actuation with a maximum recommended daily dose of 200 micrograms (as a single dose) in a pack containing 200 actuations or less

67

Folic acid; for oral use in medicines containing more than 500 micrograms per recommended daily dose; except for oral use in medicines containing 500 micrograms or less per recommended daily dose; except in parenteral nutrition replacement preparations

68

Folinic acid; for oral use in medicines containing more than 500 micrograms per recommended daily dose; except for oral use in medicines containing 500 micrograms or less per recommended daily dose

69

Formaldehyde; except in medicines containing 5% or less

70

Gelsemium sempervirens; except in medicines containing 1 milligram or less per litre or per kilogram

71

Glutaraldehyde

72

Hexachlorophane; in medicines containing 3% or less but more than 0.75%; except in medicines containing 0.75% or less

73

Hydrocortisone and hydrocortisone acetate but no other esters of hydrocortisone; for dermal use in medicines containing 0.5% or less by weight of hydrocortisone base with no other active ingredient except an antifungal and in a quantity of 30 grams or less or 30 millilitres or less per container; in rectal medicines containing 0.5% or less by weight of hydrocortisone base and in combination with a local anaesthetic and in a quantity of 35 grams or less per container or 12 suppositories or fewer per pack

74

Hydrocyanic acid; for oral use in packs containing 5 milligrams or less and more than 0.5 milligrams; except in medicines containing 1 microgram or less per litre or per kilogram; except for oral use in packs containing 0.5 milligrams or less

75

Hydroquinone; for external use in medicines containing 2% or less except in hair preparations containing 1% or less

76

Hyoscine; for transdermal use in medicines containing 2 milligrams or less of total solanaceous alkaloids per dose unit; for oral use in liquid form in medicines containing 0.03% or less and 0.3 milligrams or less per dose and not more than 1.2 milligrams per recommended daily dose of total solanaceous alkaloids; in solid dose form in medicines containing 0.3 milligrams or less per dose form and not more than 1.2 milligrams per recommended daily dose of total solanaceous alkaloids

77

Hyoscyamine; for external use in medicines containing 0.03% or less of total solanaceous alkaloids; for oral use in liquid form in medicines containing 0.03% or less and 0.3 milligrams or less per dose and not more than 1.2 milligrams per recommended daily dose of total solanaceous alkaloids; in solid dose form in medicines containing 0.3 milligrams or less per dose form and not more than 1.2 milligrams per recommended daily dose of total solanaceous alkaloids

78

Hyoscyamus niger; for oral use in liquid form in medicines containing 0.03% or less (300 micrograms or less of total solanaceous alkaloids per litre or per kilogram) and 0.3 milligrams or less per dose and not more than 1.2 milligrams per recommended daily dose of total solanaceous alkaloids or in solid dose form in medicines containing 0.3 milligrams or less per dose form and not more than 1.2 milligrams per recommended daily dose except in packs containing 30 micrograms or less of total solanaceous alkaloids

79

Ibuprofen; for oral use in liquid form with a recommended daily dose of not more than 1.2 grams for the relief of pain and reduction of fever or inflammation when sold in the manufacturer’s original pack containing not more than 8 grams; for oral use in solid dose form containing not more than 200 milligrams per dose form and with a recommended daily dose of not more than 1.2 grams when sold in the manufacturer’s original pack containing not more than 100 dose units; except in divided solid dosage forms for oral use containing 200 milligrams or less per dose form with a recommended daily dose of not more than 1.2 grams and when sold in the manufacturer’s original pack containing not more than 25 dose units; except for external use

80

Indanazoline

81

Indomethacin; for external use in medicines containing 1% or less; except in medicines containing 1 milligram or less per litre or per kilogram

82

Iodine; except for external use in medicines containing 2.5% or less; for internal use in medicines containing less than 300 micrograms per recommended daily dose

83

Ipecacuanha; in medicines containing 0.2% or less of emetine and 40 micrograms or more of ipecacuanha alkaloids per recommended dose for the treatment of the symptoms of cough and cold in children aged 6–12 years; except in medicines containing less than 40 micrograms of ipecacuanha alkaloids per recommended dose for the treatment of the symptoms of cough and cold in children aged 6–12 years

84

Ipomoea spp; except ipomoea batatas

85

Ipratropium; for nasal use

86

Iron; for oral use either in medicines containing more than 24 milligrams per recommended daily dose or in medicines containing more than 5 milligrams per dose unit and more than 750 milligrams of iron per pack; except in parenteral nutrition replacement preparations; except for oral use in medicines containing 24 milligrams or less per recommended daily dose in medicines containing not more than 5 milligrams per dose unit; except for oral use in medicines containing 24 milligrams or less per recommended daily dose in medicines containing more than 5 milligrams per dose unit in packs containing not more than 750 milligrams of iron

87

Isoconazole; for dermal use except when sold in practice by a podiatrist registered with the Podiatrists Board

88

Isopropamide; for dermal use in preparations containing 2% or less

89

Jalap resin

90

Ketoconazole; for dermal use except in medicines for tinea pedis only or when sold in practice by a podiatrist registered with the Podiatrists Board; except in medicines for treatment of the scalp containing 1% or less

91

Ketotifen; for ophthalmic use in medicines containing 0.025% or less except when sold in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board

92

Leucovorin; in medicines containing more than 500 micrograms per recommended daily dose

93

Levocabastine; for nasal use; for ophthalmic use except when sold in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board

94

Levocetirizine; for oral use

95

Lignocaine; for urethral use; for external use in medicines containing 10% or less and more than 2%

96

Lindane; for external use in medicines containing 2% or less

97

Lithium; for dermal use in medicines containing 1% or less but more than 0.01%; except for dermal use in medicines containing 0.01% or less

98

Lobelia inflata; except in medicines for smoking or burning

99

Lobeline; except when in medicines for smoking or burning

100

Lodoxamide; for ophthalmic use except when sold in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board

101

Loperamide; in packs containing not more than 20 tablets or capsules; except in divided solid dosage forms for oral use containing 2 milligrams or less of loperamide per dosage form when sold in a pack containing not more than 8 dosage forms approved by the Minister or the Director-General for distribution as a general sales medicine for the symptomatic treatment of acute non-specific diarrhoea

102

Loratadine; for oral use; except in divided solid dosage forms for oral use containing 10 milligrams or less per dose form for the treatment of seasonal allergic rhinitis when sold in the manufacturer’s original pack containing not more than 10 days’ supply

103

Macrogols; in preparations for oral use as a liquid concentrate for laxative use

104

Mebendazole

105

Meclozine; in a sealed container of not more than 12 tablets or capsules for the prevention or treatment of travel sickness except when sold at a transport terminal or aboard a ship or aircraft

106

Mefenamic acid; in solid dose form in packs containing not more than 30 tablets or capsules for the treatment of dysmenorrhoea

107

Mepyramine; for dermal use; except for external use in medicines containing 2% or less in packs not exceeding 25 grams

108

Mercuric oxide; for ophthalmic use

109

Mercurochrome; in preparations for external use containing 2% or less

110

Mercury; for external use in medicines containing 0.5% or less; except in medicines containing 1 milligram or less per litre or per kilogram

111

Methoxamine; for external use in medicines containing more than 1%; except for external use in medicines containing 1% or less

112

Methoxyphenamine

113

Methylephedrine

114

Miconazole; for external use except in medicines for tinea pedis only or when sold in practice by a podiatrist registered with the Podiatrists Board

115

Minoxidil; for dermal use in medicines containing 5% or less

116

Mometasone; for the treatment or prophylaxis of allergic rhinitis in adults and children over 12 years of age in aqueous nasal sprays delivering up to 50 micrograms per actuation when the maximum recommended daily dose is no greater than 200 micrograms (as a single dose) in a pack containing 200 actuations or less

117

Morphine; in medicines for oral use containing not more than 0.2% of morphine, when combined with 1 or more active ingredients in such a way that the substance cannot be recovered by readily applicable means or in a yield that would constitute a risk to health, when sold in a pack approved by the Minister or the Director-General for distribution as a pharmacy-only medicine

118

Naphazoline; except for ophthalmic use when sold in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board

119

Naproxen; in solid dose form containing 250 milligrams or less per dose form in packs of not more than 30 tablets or capsules

120

Niclosamide

121

Nicotine; for inhalation except when sold from a smoking cessation clinic run under the auspices of a registered medical practitioner, nurse, pharmacist, or psychologist

122

Nizatidine; in medicines for the symptomatic relief of heartburn, dyspepsia, and hyperacidity or to be used on the recommendation of a registered medical practitioner, when sold in the manufacturer’s original pack containing not more than 14 days’ supply

123

Noscapine

124

Nystatin; for dermal use except when sold in practice by a podiatrist registered with the Podiatrists Board; except in medicines for tinea pedis only or when sold in practice by a podiatrist registered with the Podiatrists Board

125

Omeprazole; in divided solid dosage forms for oral use containing 20 milligrams or less with a maximum daily dose of 20 milligrams for the short-term symptomatic relief of gastric reflux-like symptoms in sufferers aged 18 years and over when sold in the manufacturer’s original pack containing not more than 28 dosage units

126

Opium; in medicines for oral use containing not more than 0.2% of morphine, when combined with 1 or more active ingredients in such a way that the substance cannot be recovered by readily applicable means, or in a yield that would constitute a risk to health, when sold in a pack approved by the Minister or the Director-General for distribution as a pharmacy-only medicine

127

Oxetacaine; for internal use

128

Oxiconazole; for dermal use except in medicines for tinea pedis only

129

Oxymetazoline; except for nasal use when sold at an airport; except for ophthalmic use when sold in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board; except for nasal use in medicines containing 0.05% or less when sold in the manufacturer’s original pack with a pack size of 20 millilitres or less

130

Pantoprazole; in divided solid dosage forms for oral use containing 20 milligrams or less with a maximum daily dose of 20 milligrams for the short-term symptomatic relief of gastric reflux-like symptoms in sufferers aged 18 years and over when sold in the manufacturer’s original pack containing not more than 28 dosage units

131

Papaverine; except for injection

132

Paracetamol; in liquid form; in suppositories; in tablets or capsules containing 500 milligrams or less and in packs containing more than 10 grams and not more than 50 grams; in slow-release forms containing 665 milligrams or less and more than 500 milligrams; in powder form containing not more than 1 gram per sachet and more than 10 grams per pack; except in tablets or capsules containing 500 milligrams or less and in packs containing not more than 10 grams; except in powder form in sachets containing 1 gram or less and in packs of not more than 10 grams

133

Paraformaldehyde; except in medicines containing 5% or less

134

Penciclovir; for external use for the treatment of herpes labialis; except in medicines for external use containing 1% or less in a pack containing 10 grams or less for the treatment of herpes labialis

135

Phedrazine

136

Phenazone; for external use

137

Pheniramine; for ophthalmic use except when sold in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board; for oral use in medicines for adults and children over 6 years of age when combined in the same container with 1 or more other therapeutically active ingredients either when in the bedtime dose of a day/night pack containing pheniramine or when at least 1 of the other active ingredients is a sympathomimetic decongestant

138

Phenol; except in medicines other than for injection containing 3% or less

139

Phenylephrine; for nasal use in medicines containing more than 1%; for ophthalmic use in medicines containing 5% or less and more than 1%; for oral use in medicines containing more than 50 milligrams per recommended daily dose or in packs containing more than 250 milligrams of phenylephrine per pack; in medicines for the treatment of the symptoms of cough and cold in children aged 6–12 years; except for nasal or ophthalmic use in medicines containing 1% or less; except for oral use in medicines containing 50 milligrams or less per recommended daily dose and in packs containing 250 milligrams or less of phenylephrine per pack

140

Pholcodine; in medicines for oral use containing not more than 15 milligrams of pholcodine per solid dosage unit or per dose of liquid with a maximum daily dose not exceeding 100 milligrams of pholcodine, when combined with 1 or more active ingredients in such a way that the substance cannot be recovered by readily applicable means, or in a yield that would constitute a risk to health, when sold in a pack approved by the Minister or the Director-General for distribution as a pharmacy-only medicine

141

Piperazine

142

Podophyllotoxin; for external use for the treatment of warts other than anogenital warts in medicines containing 0.5% or less; except in medicines containing 1 milligram or less of podophyllin per litre or per kilogram

143

Podophyllum emodi; for external use for the treatment of warts other than anogenital warts in medicines containing 10% or less of podophyllin; except in medicines containing 1 milligram or less of podophyllin per litre or per kilogram

144

Podophyllum peltatum; for external use for the treatment of warts other than anogenital warts in medicines containing 10% or less of podophyllin; except in medicines containing 1 milligram or less of podophyllin per litre or per kilogram

145

Potassium; for internal use: in slow-release or enteric coated forms; except for internal use: in medicines containing 100 milligrams or less per recommended dose; in medicines containing more than 100 milligrams per recommended dose except in medicines for oral rehydration therapy, parenteral nutrition replacement, or dialysis; except in glucosamine sulphate complexed products containing 600 milligrams or less of potassium chloride per recommended dose; except for external use

146

Potassium chlorate; except in medicines containing 10% or less

147

Prilocaine; for dermal use in medicines containing 10% or less of local anaesthetic substances

148

Procyclidine; for dermal use in medicines containing 5% or less

149

Promethazine; for oral use in medicines for adults and children over 6 years of age when combined in the same container with 1 or more other therapeutically active ingredients either when in the bedtime dose of a day/night pack containing promethazine or when at least 1 of the other active ingredients is a sympathomimetic decongestant; for oral use in a sealed container of not more than 10 tablets or capsules for the prevention or treatment of motion sickness in adults and children over 2 years of age except when sold at a transport terminal or aboard a ship or aircraft

150

Propamidine; for ophthalmic use except when sold in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board

151

Pyrantel

152

Pyrethrins; except in medicines containing 10% or less

153

Pyrithione zinc; except in medicines for treatment of the scalp containing 2% or less

154

Ranitidine; in medicines for the symptomatic relief of heartburn, dyspepsia, and hyperacidity or to be used on the recommendation of a registered medical practitioner when sold in the manufacturer’s original pack containing not more than 14 days’ supply; except in medicines containing 300 milligrams or less per dose unit when sold in the manufacturer’s original pack containing not more than 7 days’ supply

155

Salicylamide

156

Selenium; for oral use in medicines containing 300 micrograms or less and more than 150 micrograms per recommended daily dose; for external use except in medicines containing 3.5% or less of selenium sulphide

157

Sennosides

158

Silver; except in oral solutions containing 0.3% or less or other medicines containing 1% or less

159

Silver sulfadiazine; for external use in pack sizes of 50 grams or less

160

Sodium cromoglycate; for nasal use; for ophthalmic use except when sold in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board

161

Sodium nitrite; except for use as an excipient

162

Sodium picosulphate; in oral laxative preparations

163

Squill; except in medicines containing 1% or less

164

Stramonium; for oral use in liquid form in medicines containing 0.03% or less and 0.3 milligrams or less per dose and not more than 1.2 milligrams per recommended daily dose of total solanaceous alkaloids; in solid dose form in medicines containing 0.3 milligrams or less per dose form and not more than 1.2 milligrams per recommended daily dose of total solanaceous alkaloids

165

Sulconazole; for dermal use

166

Sulfadiazine, silver; for external use in pack sizes of 50 grams or less

167

Terbinafine; for dermal use except in medicines for tinea pedis only or when sold in practice by a podiatrist registered with the Podiatrists Board

168

Tetrachloroethylene

169

Tetrahydrozoline; except for ophthalmic use when sold in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board

170

Thiabendazole

171

Tioconazole; for dermal use except in medicines for tinea pedis only or when sold in practice by a podiatrist registered with the Podiatrists Board

172

Tramazoline

173

Triamcinolone; for the treatment or prophylaxis of allergic rhinitis in adults and children over 12 years of age and when in aqueous nasal sprays delivering up to 55 micrograms per actuation when the maximum recommended daily dose is no greater than 220 micrograms and the medicine has received the consent of the Minister or the Director-General to its distribution as a pharmacy-only medicine

174

Trimeprazine; for oral use in medicines for adults and children over 6 years of age when combined in the same container with 1 or more other therapeutically active ingredients either when in the bedtime dose of a day/night pack containing trimeprazine or when at least 1 of the other therapeutically active ingredients is a sympathomimetic decongestant

175

Triprolidine; for oral use in medicines for adults and children over 6 years of age when combined in the same container with 1 or more other therapeutically active ingredients either when in the bedtime dose of a day/night pack containing triprolidine or when at least 1 of the other active ingredients is a sympathomimetic decongestant

176

Tuaminoheptane

177

Tymazoline

178

Xylenols; except in medicines containing 3% or less

179

Xylometazoline; except for nasal use when sold at an airport; except for ophthalmic use when sold in practice by an optometrist registered with the Optometrists and Dispensing Opticians Board

180

Zinc chloride; for dermal use in medicines containing more than 5%

Michael Webster,
Clerk of the Executive Council.

Explanatory note

This note is not part of the regulations, but is intended to indicate their general effect.

These regulations, which come into force on the 28th day after the date of their notification in the Gazette, replace Schedule 1 of the Medicines Regulations 1984 (the principal regulations). New Schedule 1 sets out an updated list of specified medicines and classes of medicines that are declared to be prescription medicines, restricted medicines, or pharmacy-only medicines under the Medicines Act 1981 (the Act).

The updated list includes medicines that the Minister of Health has previously classified as prescription medicines, etc, by Gazette notice made under section 106 of the Act (see Classification of Medicines (Gazette 2018-go419), Classification of Medicines (Gazette 2018-go1290), Classification of Medicines (Gazette 2018-go4068), and Classification of Medicines (Gazette 2018-go4069)). Gazette notices made under section 106 override any inconsistent classification of medicines in the principal regulations, but they do not amend the principal regulations and they cease to have effect after a period of 6 months (if not revoked sooner).

Issued under the authority of the Legislation Act 2012.

Date of notification in Gazette: 27 September 2018.

Reprints notes

1 General

This is a reprint of the Medicines Amendment Regulations 2018 that incorporates all the amendments to those regulations as at the date of the last amendment to them.

2 Legal status

Reprints are presumed to correctly state, as at the date of the reprint, the law enacted by the principal enactment and by any amendments to that enactment. Section 18 of the Legislation Act 2012 provides that this reprint, published in electronic form, has the status of an official version under section 17 of that Act. A printed version of the reprint produced directly from this official electronic version also has official status.

3 Editorial and format changes

Editorial and format changes to reprints are made using the powers under sections 24 to 26 of the Legislation Act 2012. See also http://www.pco.parliament.govt.nz/editorial-conventions/.

4 Amendments incorporated in this reprint

Medicines Amendment Regulations (No 2) 2021 (LI 2021/228): regulation 5